ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count	ensembl_gene_id	gene_symbol
R-HSA-373755	Semaphorin interactions	9/247	52/7349	4.91301947112714e-05	0.0411219729733341	0.0370286520139688	4637/1808/55558/8482/388/389/1072/23396/5365	9	ENSG00000092841,ENSG00000092964,ENSG00000130827,ENSG00000138623,ENSG00000143878,ENSG00000155366,ENSG00000172757,ENSG00000186111,ENSG00000198753	MYL6,DPYSL2,PLXNA3,SEMA7A,RHOB,RHOC,CFL1,PIP5K1C,PLXNB3
R-HSA-449147	Signaling by Interleukins	25/247	333/7349	0.000126224441216493	0.0421066821298456	0.0379153422687159	1265/25930/4791/3589/4792/9049/9173/3911/301/5292/375/7316/1437/5598/1072/5970/6777/23529/3725/3932/9021/59307/5600/5034/8517	25	ENSG00000064666,ENSG00000076201,ENSG00000077150,ENSG00000095752,ENSG00000100906,ENSG00000110711,ENSG00000115602,ENSG00000130702,ENSG00000135046,ENSG00000137193,ENSG00000143761,ENSG00000150991,ENSG00000164400,ENSG00000166484,ENSG00000172757,ENSG00000173039,ENSG00000173757,ENSG00000175505,ENSG00000177606,ENSG00000182866,ENSG00000184557,ENSG00000185187,ENSG00000185386,ENSG00000185624,ENSG00000269335	CNN2,PTPN23,NFKB2,IL11,NFKBIA,AIP,IL1RL1,LAMA5,ANXA1,PIM1,ARF1,UBC,CSF2,MAPK7,CFL1,RELA,STAT5B,CLCF1,JUN,LCK,SOCS3,SIGIRR,MAPK11,P4HB,IKBKG
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	5/247	17/7349	0.000182917939813289	0.0421066821298456	0.0379153422687159	8907/375/55690/3932/161	5	ENSG00000072958,ENSG00000143761,ENSG00000175115,ENSG00000182866,ENSG00000183020	AP1M1,ARF1,PACS1,LCK,AP2A2
R-HSA-194315	Signaling by Rho GTPases	26/247	365/7349	0.00021572281763271	0.0421066821298456	0.0379153422687159	25791/5526/8655/4637/4650/80152/23370/1855/5216/1027/397/5924/4688/7277/5880/3021/50649/388/389/6396/1780/5747/1072/8349/2664/10552	26	ENSG00000066248,ENSG00000068971,ENSG00000088986,ENSG00000092841,ENSG00000099331,ENSG00000102901,ENSG00000104880,ENSG00000107404,ENSG00000108518,ENSG00000111276,ENSG00000111348,ENSG00000113319,ENSG00000116701,ENSG00000127824,ENSG00000128340,ENSG00000132475,ENSG00000136002,ENSG00000143878,ENSG00000155366,ENSG00000157020,ENSG00000158560,ENSG00000169398,ENSG00000172757,ENSG00000184678,ENSG00000203879,ENSG00000241685	NGEF,PPP2R5B,DYNLL1,MYL6,MYO9B,CENPT,ARHGEF18,DVL1,PFN1,CDKN1B,ARHGDIB,RASGRF2,NCF2,TUBA4A,RAC2,H3F3B,ARHGEF4,RHOB,RHOC,SEC13,DYNC1I1,PTK2,CFL1,HIST2H2BE,GDI1,ARPC1A
R-HSA-381119	Unfolded Protein Response (UPR)	11/247	93/7349	0.000263480105278466	0.0421066821298456	0.0379153422687159	10954/5526/118/10488/7709/23480/10113/10525/467/1649/6734	11	ENSG00000065485,ENSG00000068971,ENSG00000087274,ENSG00000107175,ENSG00000116809,ENSG00000132432,ENSG00000138073,ENSG00000149428,ENSG00000162772,ENSG00000175197,ENSG00000182934	PDIA5,PPP2R5B,ADD1,CREB3,ZBTB17,SEC61G,PREB,HYOU1,ATF3,DDIT3,SRPR
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	6/247	29/7349	0.000336071106710323	0.0421066821298456	0.0379153422687159	7185/8717/329/7316/81858/8517	6	ENSG00000056558,ENSG00000102871,ENSG00000110330,ENSG00000150991,ENSG00000179526,ENSG00000269335	TRAF1,TRADD,BIRC2,UBC,SHARPIN,IKBKG
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	5/247	20/7349	0.000421907276704357	0.0421066821298456	0.0379153422687159	8907/375/55690/3932/161	5	ENSG00000072958,ENSG00000143761,ENSG00000175115,ENSG00000182866,ENSG00000183020	AP1M1,ARF1,PACS1,LCK,AP2A2
R-HSA-381038	XBP1(S) activates chaperone genes	8/247	55/7349	0.000450487398594934	0.0421066821298456	0.0379153422687159	10954/5526/118/7709/23480/10113/10525/6734	8	ENSG00000065485,ENSG00000068971,ENSG00000087274,ENSG00000116809,ENSG00000132432,ENSG00000138073,ENSG00000149428,ENSG00000182934	PDIA5,PPP2R5B,ADD1,ZBTB17,SEC61G,PREB,HYOU1,SRPR
R-HSA-381070	IRE1alpha activates chaperones	8/247	57/7349	0.00057699300151082	0.0421066821298456	0.0379153422687159	10954/5526/118/7709/23480/10113/10525/6734	8	ENSG00000065485,ENSG00000068971,ENSG00000087274,ENSG00000116809,ENSG00000132432,ENSG00000138073,ENSG00000149428,ENSG00000182934	PDIA5,PPP2R5B,ADD1,ZBTB17,SEC61G,PREB,HYOU1,SRPR
R-HSA-5357905	Regulation of TNFR1 signaling	6/247	32/7349	0.000589167652273028	0.0421066821298456	0.0379153422687159	7185/8717/329/7316/81858/8517	6	ENSG00000056558,ENSG00000102871,ENSG00000110330,ENSG00000150991,ENSG00000179526,ENSG00000269335	TRAF1,TRADD,BIRC2,UBC,SHARPIN,IKBKG
R-HSA-933542	TRAF6 mediated NF-kB activation	5/247	22/7349	0.000678237163008369	0.0421066821298456	0.0379153422687159	4791/4214/4792/5970/8517	5	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000173039,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,RELA,IKBKG
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	10/247	88/7349	0.000689777928579637	0.0421066821298456	0.0379153422687159	4791/4214/4792/7316/5598/5970/3725/59307/5600/8517	10	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185187,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,UBC,MAPK7,RELA,JUN,SIGIRR,MAPK11,IKBKG
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	10/247	88/7349	0.000689777928579637	0.0421066821298456	0.0379153422687159	4791/4214/4792/7316/5598/5970/3725/59307/5600/8517	10	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185187,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,UBC,MAPK7,RELA,JUN,SIGIRR,MAPK11,IKBKG
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	10/247	89/7349	0.000754600038169276	0.0421066821298456	0.0379153422687159	4791/4214/4792/7316/5598/5970/3725/59307/5600/8517	10	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185187,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,UBC,MAPK7,RELA,JUN,SIGIRR,MAPK11,IKBKG
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	10/247	89/7349	0.000754600038169276	0.0421066821298456	0.0379153422687159	4791/4214/4792/7316/5598/5970/3725/59307/5600/8517	10	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185187,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,UBC,MAPK7,RELA,JUN,SIGIRR,MAPK11,IKBKG
R-HSA-195258	RHO GTPase Effectors	19/247	256/7349	0.000955593249610297	0.048327688819342	0.0435171039359226	5526/8655/4637/80152/1855/5216/1027/4688/7277/5880/3021/388/389/6396/1780/5747/1072/8349/10552	19	ENSG00000068971,ENSG00000088986,ENSG00000092841,ENSG00000102901,ENSG00000107404,ENSG00000108518,ENSG00000111276,ENSG00000116701,ENSG00000127824,ENSG00000128340,ENSG00000132475,ENSG00000143878,ENSG00000155366,ENSG00000157020,ENSG00000158560,ENSG00000169398,ENSG00000172757,ENSG00000184678,ENSG00000241685	PPP2R5B,DYNLL1,MYL6,CENPT,DVL1,PFN1,CDKN1B,NCF2,TUBA4A,RAC2,H3F3B,RHOB,RHOC,SEC13,DYNC1I1,PTK2,CFL1,HIST2H2BE,ARPC1A
R-HSA-73887	Death Receptor Signalling	12/247	127/7349	0.0011090356635691	0.048327688819342	0.0435171039359226	7185/25791/4792/8717/23370/329/5924/50649/7316/5970/81858/8517	12	ENSG00000056558,ENSG00000066248,ENSG00000100906,ENSG00000102871,ENSG00000104880,ENSG00000110330,ENSG00000113319,ENSG00000136002,ENSG00000150991,ENSG00000173039,ENSG00000179526,ENSG00000269335	TRAF1,NGEF,NFKBIA,TRADD,ARHGEF18,BIRC2,RASGRF2,ARHGEF4,UBC,RELA,SHARPIN,IKBKG
R-HSA-1280215	Cytokine Signaling in Immune system	30/247	495/7349	0.00110923637943375	0.048327688819342	0.0435171039359226	1265/25930/4791/3589/4792/5971/329/9049/9173/3664/3911/301/5292/375/7316/80128/1437/5598/1072/5970/6777/23529/3725/3932/9021/59307/5600/402569/5034/8517	30	ENSG00000064666,ENSG00000076201,ENSG00000077150,ENSG00000095752,ENSG00000100906,ENSG00000104856,ENSG00000110330,ENSG00000110711,ENSG00000115602,ENSG00000117595,ENSG00000130702,ENSG00000135046,ENSG00000137193,ENSG00000143761,ENSG00000150991,ENSG00000163462,ENSG00000164400,ENSG00000166484,ENSG00000172757,ENSG00000173039,ENSG00000173757,ENSG00000175505,ENSG00000177606,ENSG00000182866,ENSG00000184557,ENSG00000185187,ENSG00000185386,ENSG00000185467,ENSG00000185624,ENSG00000269335	CNN2,PTPN23,NFKB2,IL11,NFKBIA,RELB,BIRC2,AIP,IL1RL1,IRF6,LAMA5,ANXA1,PIM1,ARF1,UBC,TRIM46,CSF2,MAPK7,CFL1,RELA,STAT5B,CLCF1,JUN,LCK,SOCS3,SIGIRR,MAPK11,KPNA7,P4HB,IKBKG
R-HSA-1474228	Degradation of the extracellular matrix	9/247	78/7349	0.00113870187629383	0.048327688819342	0.0435171039359226	64386/7077/3918/1294/1509/3911/1515/5045/3914	9	ENSG00000008516,ENSG00000035862,ENSG00000058085,ENSG00000114270,ENSG00000117984,ENSG00000130702,ENSG00000136943,ENSG00000140564,ENSG00000196878	MMP25,TIMP2,LAMC2,COL7A1,CTSD,LAMA5,CTSV,FURIN,LAMB3
R-HSA-76002	Platelet activation, signaling and aggregation	15/247	182/7349	0.00115478348433314	0.048327688819342	0.0435171039359226	2769/10235/2782/5216/2771/5768/7277/5880/5894/388/7424/5747/1072/3932/7114	15	ENSG00000060558,ENSG00000068831,ENSG00000078369,ENSG00000108518,ENSG00000114353,ENSG00000116260,ENSG00000127824,ENSG00000128340,ENSG00000132155,ENSG00000143878,ENSG00000150630,ENSG00000169398,ENSG00000172757,ENSG00000182866,ENSG00000205542	GNA15,RASGRP2,GNB1,PFN1,GNAI2,QSOX1,TUBA4A,RAC2,RAF1,RHOB,VEGFC,PTK2,CFL1,LCK,TMSB4X
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	9/247	80/7349	0.00136609517610926	0.0497139853218891	0.0447654071439007	4791/4214/4792/7316/5598/5970/3725/5600/8517	9	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,UBC,MAPK7,RELA,JUN,MAPK11,IKBKG
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	9/247	80/7349	0.00136609517610926	0.0497139853218891	0.0447654071439007	4791/4214/4792/7316/5598/5970/3725/5600/8517	9	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,UBC,MAPK7,RELA,JUN,MAPK11,IKBKG
R-HSA-975871	MyD88 cascade initiated on plasma membrane	9/247	80/7349	0.00136609517610926	0.0497139853218891	0.0447654071439007	4791/4214/4792/7316/5598/5970/3725/5600/8517	9	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,UBC,MAPK7,RELA,JUN,MAPK11,IKBKG
R-HSA-168898	Toll-Like Receptors Cascades	12/247	131/7349	0.00145355608960366	0.0506927686249275	0.0456467614103605	4791/4214/4792/329/1515/7316/5598/5970/3725/59307/5600/8517	12	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000110330,ENSG00000136943,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185187,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,BIRC2,CTSV,UBC,MAPK7,RELA,JUN,SIGIRR,MAPK11,IKBKG
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	11/247	117/7349	0.00184609801173431	0.0618073614328646	0.0556549969011269	4791/4214/4792/329/7316/5598/5970/3725/59307/5600/8517	11	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000110330,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185187,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,BIRC2,UBC,MAPK7,RELA,JUN,SIGIRR,MAPK11,IKBKG
R-HSA-1592389	Activation of Matrix Metalloproteinases	4/247	17/7349	0.00209763173693305	0.0656686896695622	0.0591319647908024	64386/7077/1515/5045	4	ENSG00000008516,ENSG00000035862,ENSG00000136943,ENSG00000140564	MMP25,TIMP2,CTSV,FURIN
R-HSA-422475	Axon guidance	26/247	427/7349	0.00224469452373043	0.0656686896695622	0.0591319647908024	25791/4637/1808/4650/5216/7277/55558/5962/8482/388/7220/7316/389/3678/5598/784/5747/1072/22885/161/5600/23396/9260/5365/3897/10552	26	ENSG00000066248,ENSG00000092841,ENSG00000092964,ENSG00000099331,ENSG00000108518,ENSG00000127824,ENSG00000130827,ENSG00000137710,ENSG00000138623,ENSG00000143878,ENSG00000144935,ENSG00000150991,ENSG00000155366,ENSG00000161638,ENSG00000166484,ENSG00000167535,ENSG00000169398,ENSG00000172757,ENSG00000173210,ENSG00000183020,ENSG00000185386,ENSG00000186111,ENSG00000196923,ENSG00000198753,ENSG00000198910,ENSG00000241685	NGEF,MYL6,DPYSL2,MYO9B,PFN1,TUBA4A,PLXNA3,RDX,SEMA7A,RHOB,TRPC1,UBC,RHOC,ITGA5,MAPK7,CACNB3,PTK2,CFL1,ABLIM3,AP2A2,MAPK11,PIP5K1C,PDLIM7,PLXNB3,L1CAM,ARPC1A
R-HSA-416482	G alpha (12/13) signalling events	8/247	70/7349	0.00226522456419165	0.0656686896695622	0.0591319647908024	25791/2782/23370/5924/5880/50649/388/389	8	ENSG00000066248,ENSG00000078369,ENSG00000104880,ENSG00000113319,ENSG00000128340,ENSG00000136002,ENSG00000143878,ENSG00000155366	NGEF,GNB1,ARHGEF18,RASGRF2,RAC2,ARHGEF4,RHOB,RHOC
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	9/247	86/7349	0.00227525925975783	0.0656686896695622	0.0591319647908024	4791/4214/4792/7316/5598/5970/3725/5600/8517	9	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,UBC,MAPK7,RELA,JUN,MAPK11,IKBKG
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	8/247	71/7349	0.00248045164429951	0.0676548874103579	0.0609204544876014	51343/1027/3021/7316/5598/5970/3725/8349	8	ENSG00000105325,ENSG00000111276,ENSG00000132475,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000184678	FZR1,CDKN1B,H3F3B,UBC,MAPK7,RELA,JUN,HIST2H2BE
R-HSA-75893	TNF signaling	6/247	42/7349	0.00257617564424595	0.0676548874103579	0.0609204544876014	7185/8717/329/7316/81858/8517	6	ENSG00000056558,ENSG00000102871,ENSG00000110330,ENSG00000150991,ENSG00000179526,ENSG00000269335	TRAF1,TRADD,BIRC2,UBC,SHARPIN,IKBKG
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	9/247	88/7349	0.00266739699467361	0.0676548874103579	0.0609204544876014	4791/4214/4792/7316/5598/5970/3725/5600/8517	9	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,UBC,MAPK7,RELA,JUN,MAPK11,IKBKG
R-HSA-975155	MyD88 dependent cascade initiated on endosome	9/247	88/7349	0.00266739699467361	0.0676548874103579	0.0609204544876014	4791/4214/4792/7316/5598/5970/3725/5600/8517	9	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,UBC,MAPK7,RELA,JUN,MAPK11,IKBKG
R-HSA-5260271	Diseases of Immune System	4/247	19/7349	0.00324023923697763	0.0732994659824399	0.0660031662496723	4791/4792/5970/8517	4	ENSG00000077150,ENSG00000100906,ENSG00000173039,ENSG00000269335	NFKB2,NFKBIA,RELA,IKBKG
R-HSA-5602358	Diseases associated with the TLR signaling cascade	4/247	19/7349	0.00324023923697763	0.0732994659824399	0.0660031662496723	4791/4792/5970/8517	4	ENSG00000077150,ENSG00000100906,ENSG00000173039,ENSG00000269335	NFKB2,NFKBIA,RELA,IKBKG
R-HSA-5625900	RHO GTPases activate CIT	4/247	19/7349	0.00324023923697763	0.0732994659824399	0.0660031662496723	4637/1027/388/389	4	ENSG00000092841,ENSG00000111276,ENSG00000143878,ENSG00000155366	MYL6,CDKN1B,RHOB,RHOC
R-HSA-5627117	RHO GTPases Activate ROCKs	4/247	19/7349	0.00324023923697763	0.0732994659824399	0.0660031662496723	4637/388/389/1072	4	ENSG00000092841,ENSG00000143878,ENSG00000155366,ENSG00000172757	MYL6,RHOB,RHOC,CFL1
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	5/247	31/7349	0.00341959855249185	0.0753211575904125	0.0678236167197829	4791/4792/7316/5970/8517	5	ENSG00000077150,ENSG00000100906,ENSG00000150991,ENSG00000173039,ENSG00000269335	NFKB2,NFKBIA,UBC,RELA,IKBKG
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	9/247	92/7349	0.00361149726921326	0.0775082875469615	0.0697930376452549	4791/4214/4792/7316/5598/5970/3725/5600/8517	9	ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185386,ENSG00000269335	NFKB2,MAP3K1,NFKBIA,UBC,MAPK7,RELA,JUN,MAPK11,IKBKG
R-HSA-209560	NF-kB is activated and signals survival	3/247	10/7349	0.00377707714768991	0.0786146715247012	0.0707892910918519	4792/7316/5970	3	ENSG00000100906,ENSG00000150991,ENSG00000173039	NFKBIA,UBC,RELA
R-HSA-432720	Lysosome Vesicle Biogenesis	5/247	32/7349	0.00394375242290274	0.0786146715247012	0.0707892910918519	8907/375/9146/8906/9179	5	ENSG00000072958,ENSG00000143761,ENSG00000185359,ENSG00000213983,ENSG00000221838	AP1M1,ARF1,HGS,AP1G2,AP4M1
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	4/247	20/7349	0.00394482222704594	0.0786146715247012	0.0707892910918519	4791/4792/5970/8517	4	ENSG00000077150,ENSG00000100906,ENSG00000173039,ENSG00000269335	NFKB2,NFKBIA,RELA,IKBKG
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	8/247	77/7349	0.00412888429974714	0.0803692129974036	0.0723691838095214	29924/22905/8301/58513/1861/7316/161/9146	8	ENSG00000063245,ENSG00000072134,ENSG00000073921,ENSG00000127527,ENSG00000136827,ENSG00000150991,ENSG00000183020,ENSG00000185359	EPN1,EPN2,PICALM,EPS15L1,TOR1A,UBC,AP2A2,HGS
R-HSA-2672351	Stimuli-sensing channels	7/247	62/7349	0.00452296493449956	0.0860391284130939	0.0774747103612843	59341/65266/5894/7220/7316/1193/162514	7	ENSG00000111199,ENSG00000126562,ENSG00000132155,ENSG00000144935,ENSG00000150991,ENSG00000155962,ENSG00000167723	TRPV4,WNK4,RAF1,TRPC1,UBC,CLIC2,TRPV3
R-HSA-8874081	MET activates PTK2 signaling	4/247	21/7349	0.00474625971833744	0.0873414047118463	0.0786473568178104	3918/3911/5747/3914	4	ENSG00000058085,ENSG00000130702,ENSG00000169398,ENSG00000196878	LAMC2,LAMA5,PTK2,LAMB3
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	9/247	96/7349	0.00480012499013731	0.0873414047118463	0.0786473568178104	4791/4792/329/7316/5598/5970/3725/5600/8517	9	ENSG00000077150,ENSG00000100906,ENSG00000110330,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185386,ENSG00000269335	NFKB2,NFKBIA,BIRC2,UBC,MAPK7,RELA,JUN,MAPK11,IKBKG
R-HSA-166166	MyD88-independent TLR4 cascade 	9/247	97/7349	0.00514010238726248	0.0896305353778895	0.0807086252035073	4791/4792/329/7316/5598/5970/3725/5600/8517	9	ENSG00000077150,ENSG00000100906,ENSG00000110330,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185386,ENSG00000269335	NFKB2,NFKBIA,BIRC2,UBC,MAPK7,RELA,JUN,MAPK11,IKBKG
R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling 	9/247	97/7349	0.00514010238726248	0.0896305353778895	0.0807086252035073	4791/4792/329/7316/5598/5970/3725/5600/8517	9	ENSG00000077150,ENSG00000100906,ENSG00000110330,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000185386,ENSG00000269335	NFKB2,NFKBIA,BIRC2,UBC,MAPK7,RELA,JUN,MAPK11,IKBKG
R-HSA-8856828	Clathrin-mediated endocytosis	10/247	116/7349	0.00549371108831585	0.0927308152850911	0.0835003002504248	29924/22905/8301/58513/1861/7316/161/9146/23396/10552	10	ENSG00000063245,ENSG00000072134,ENSG00000073921,ENSG00000127527,ENSG00000136827,ENSG00000150991,ENSG00000183020,ENSG00000185359,ENSG00000186111,ENSG00000241685	EPN1,EPN2,PICALM,EPS15L1,TOR1A,UBC,AP2A2,HGS,PIP5K1C,ARPC1A
R-HSA-182971	EGFR downregulation	4/247	22/7349	0.00565026473063279	0.0927308152850911	0.0835003002504248	29924/58513/7316/9146	4	ENSG00000063245,ENSG00000127527,ENSG00000150991,ENSG00000185359	EPN1,EPS15L1,UBC,HGS
R-HSA-3000157	Laminin interactions	4/247	22/7349	0.00565026473063279	0.0927308152850911	0.0835003002504248	3918/1294/3911/3914	4	ENSG00000058085,ENSG00000114270,ENSG00000130702,ENSG00000196878	LAMC2,COL7A1,LAMA5,LAMB3
R-HSA-2132295	MHC class II antigen presentation	9/247	99/7349	0.00587590282566693	0.0928803496934096	0.0836349498591225	8907/8655/1509/7277/1515/375/6396/1780/161	9	ENSG00000072958,ENSG00000088986,ENSG00000117984,ENSG00000127824,ENSG00000136943,ENSG00000143761,ENSG00000157020,ENSG00000158560,ENSG00000183020	AP1M1,DYNLL1,CTSD,TUBA4A,CTSV,ARF1,SEC13,DYNC1I1,AP2A2
R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	7/247	65/7349	0.00588131246565198	0.0928803496934096	0.0836349498591225	55593/4791/4214/4792/7316/5970/8517	7	ENSG00000068308,ENSG00000077150,ENSG00000095015,ENSG00000100906,ENSG00000150991,ENSG00000173039,ENSG00000269335	OTUD5,NFKB2,MAP3K1,NFKBIA,UBC,RELA,IKBKG
R-HSA-1474244	Extracellular matrix organization	13/247	176/7349	0.00621639326777834	0.0945142123676835	0.0851061762626692	64386/7077/3918/1294/1509/6385/3911/1515/5045/3678/4054/5034/3914	13	ENSG00000008516,ENSG00000035862,ENSG00000058085,ENSG00000114270,ENSG00000117984,ENSG00000124145,ENSG00000130702,ENSG00000136943,ENSG00000140564,ENSG00000161638,ENSG00000168056,ENSG00000185624,ENSG00000196878	MMP25,TIMP2,LAMC2,COL7A1,CTSD,SDC4,LAMA5,CTSV,FURIN,ITGA5,LTBP3,P4HB,LAMB3
R-HSA-194840	Rho GTPase cycle	10/247	119/7349	0.00656583731379291	0.0945142123676835	0.0851061762626692	25791/4650/23370/397/5924/5880/50649/388/389/2664	10	ENSG00000066248,ENSG00000099331,ENSG00000104880,ENSG00000111348,ENSG00000113319,ENSG00000128340,ENSG00000136002,ENSG00000143878,ENSG00000155366,ENSG00000203879	NGEF,MYO9B,ARHGEF18,ARHGDIB,RASGRF2,RAC2,ARHGEF4,RHOB,RHOC,GDI1
R-HSA-3295583	TRP channels	3/247	12/7349	0.00658804377377306	0.0945142123676835	0.0851061762626692	59341/7220/162514	3	ENSG00000111199,ENSG00000144935,ENSG00000167723	TRPV4,TRPC1,TRPV3
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	5/247	36/7349	0.00662109101201491	0.0945142123676835	0.0851061762626692	6659/7090/7316/1487/56998	5	ENSG00000124766,ENSG00000140332,ENSG00000150991,ENSG00000159692,ENSG00000178585	SOX4,TLE3,UBC,CTBP1,CTNNBIP1
R-HSA-9020591	Interleukin-12 signaling	5/247	36/7349	0.00662109101201491	0.0945142123676835	0.0851061762626692	1265/9049/375/1072/5034	5	ENSG00000064666,ENSG00000110711,ENSG00000143761,ENSG00000172757,ENSG00000185624	CNN2,AIP,ARF1,CFL1,P4HB
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	4/247	23/7349	0.00666229215017124	0.0945142123676835	0.0851061762626692	4791/4792/5970/8517	4	ENSG00000077150,ENSG00000100906,ENSG00000173039,ENSG00000269335	NFKB2,NFKBIA,RELA,IKBKG
R-HSA-199977	ER to Golgi Anterograde Transport	11/247	141/7349	0.00773251271548539	0.107868552381021	0.0971312123559218	381/8655/11316/10652/1294/7277/10113/375/6396/1780/6811	11	ENSG00000004059,ENSG00000088986,ENSG00000105669,ENSG00000106636,ENSG00000114270,ENSG00000127824,ENSG00000138073,ENSG00000143761,ENSG00000157020,ENSG00000158560,ENSG00000162236	ARF5,DYNLL1,COPE,YKT6,COL7A1,TUBA4A,PREB,ARF1,SEC13,DYNC1I1,STX5
R-HSA-195721	Signaling by WNT	16/247	245/7349	0.00823439606857595	0.112782330609762	0.101555868347595	5526/2782/64840/1855/22943/5216/6659/5880/3021/7090/7316/1487/56998/23513/161/8349	16	ENSG00000068971,ENSG00000078369,ENSG00000102312,ENSG00000107404,ENSG00000107984,ENSG00000108518,ENSG00000124766,ENSG00000128340,ENSG00000132475,ENSG00000140332,ENSG00000150991,ENSG00000159692,ENSG00000178585,ENSG00000180900,ENSG00000183020,ENSG00000184678	PPP2R5B,GNB1,PORCN,DVL1,DKK1,PFN1,SOX4,RAC2,H3F3B,TLE3,UBC,CTBP1,CTNNBIP1,SCRIB,AP2A2,HIST2H2BE
R-HSA-193639	p75NTR signals via NF-kB	3/247	13/7349	0.00835424671183424	0.112782330609762	0.101555868347595	4792/7316/5970	3	ENSG00000100906,ENSG00000150991,ENSG00000173039	NFKBIA,UBC,RELA
R-HSA-437239	Recycling pathway of L1	5/247	39/7349	0.00932110930363101	0.123837595033955	0.111510681059312	1808/7277/5962/161/3897	5	ENSG00000092964,ENSG00000127824,ENSG00000137710,ENSG00000183020,ENSG00000198910	DPYSL2,TUBA4A,RDX,AP2A2,L1CAM
R-HSA-948021	Transport to the Golgi and subsequent modification	12/247	165/7349	0.009481905145399	0.124005540729671	0.111661909278054	381/2530/8655/11316/10652/1294/7277/10113/375/6396/1780/6811	12	ENSG00000004059,ENSG00000033170,ENSG00000088986,ENSG00000105669,ENSG00000106636,ENSG00000114270,ENSG00000127824,ENSG00000138073,ENSG00000143761,ENSG00000157020,ENSG00000158560,ENSG00000162236	ARF5,FUT8,DYNLL1,COPE,YKT6,COL7A1,TUBA4A,PREB,ARF1,SEC13,DYNC1I1,STX5
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	3/247	14/7349	0.0103721515160065	0.132967481784576	0.119731770053143	2782/2771/784	3	ENSG00000078369,ENSG00000114353,ENSG00000167535	GNB1,GNAI2,CACNB3
R-HSA-6807878	COPI-mediated anterograde transport	8/247	90/7349	0.0104848910367766	0.132967481784576	0.119731770053143	381/8655/11316/10652/7277/375/1780/6811	8	ENSG00000004059,ENSG00000088986,ENSG00000105669,ENSG00000106636,ENSG00000127824,ENSG00000143761,ENSG00000158560,ENSG00000162236	ARF5,DYNLL1,COPE,YKT6,TUBA4A,ARF1,DYNC1I1,STX5
R-HSA-5663220	RHO GTPases Activate Formins	10/247	130/7349	0.0119410001255893	0.148092679243688	0.133351390729398	5526/8655/80152/1855/5216/7277/388/389/6396/1780	10	ENSG00000068971,ENSG00000088986,ENSG00000102901,ENSG00000107404,ENSG00000108518,ENSG00000127824,ENSG00000143878,ENSG00000155366,ENSG00000157020,ENSG00000158560	PPP2R5B,DYNLL1,CENPT,DVL1,PFN1,TUBA4A,RHOB,RHOC,SEC13,DYNC1I1
R-HSA-2559583	Cellular Senescence	11/247	150/7349	0.0120314243591049	0.148092679243688	0.133351390729398	9448/51343/1027/3021/2113/7316/5598/5970/3725/8349/5600	11	ENSG00000071054,ENSG00000105325,ENSG00000111276,ENSG00000132475,ENSG00000134954,ENSG00000150991,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000184678,ENSG00000185386	MAP4K4,FZR1,CDKN1B,H3F3B,ETS1,UBC,MAPK7,RELA,JUN,HIST2H2BE,MAPK11
R-HSA-175474	Assembly Of The HIV Virion	3/247	15/7349	0.0126480601905055	0.151824780902632	0.136711995379846	5045/7316/51271	3	ENSG00000140564,ENSG00000150991,ENSG00000165006	FURIN,UBC,UBAP1
R-HSA-447115	Interleukin-12 family signaling	5/247	42/7349	0.0126974129787147	0.151824780902632	0.136711995379846	1265/9049/375/1072/5034	5	ENSG00000064666,ENSG00000110711,ENSG00000143761,ENSG00000172757,ENSG00000185624	CNN2,AIP,ARF1,CFL1,P4HB
R-HSA-8956319	Nucleobase catabolism	4/247	28/7349	0.0135135103766047	0.159307157538283	0.14344956900888	1890/7378/955/79873	4	ENSG00000025708,ENSG00000183696,ENSG00000197586,ENSG00000275074	TYMP,UPP1,ENTPD6,NUDT18
R-HSA-8953897	Cellular responses to external stimuli	23/247	420/7349	0.0137920721707221	0.160332838984644	0.14437315313212	9448/8655/8897/51343/1027/4688/25824/7277/84971/3021/2113/7316/26353/1780/5598/5970/3725/8349/5600/5034/79065/3303/112398	23	ENSG00000071054,ENSG00000088986,ENSG00000100330,ENSG00000105325,ENSG00000111276,ENSG00000116701,ENSG00000126432,ENSG00000127824,ENSG00000130734,ENSG00000132475,ENSG00000134954,ENSG00000150991,ENSG00000152137,ENSG00000158560,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000184678,ENSG00000185386,ENSG00000185624,ENSG00000198925,ENSG00000204389,ENSG00000269858	MAP4K4,DYNLL1,MTMR3,FZR1,CDKN1B,NCF2,PRDX5,TUBA4A,ATG4D,H3F3B,ETS1,UBC,HSPB8,DYNC1I1,MAPK7,RELA,JUN,HIST2H2BE,MAPK11,P4HB,ATG9A,HSPA1A,EGLN2
R-HSA-2262752	Cellular responses to stress	20/247	356/7349	0.0163666188655235	0.187655616307441	0.168976194775989	9448/8655/51343/1027/4688/25824/7277/3021/2113/7316/26353/1780/5598/5970/3725/8349/5600/5034/3303/112398	20	ENSG00000071054,ENSG00000088986,ENSG00000105325,ENSG00000111276,ENSG00000116701,ENSG00000126432,ENSG00000127824,ENSG00000132475,ENSG00000134954,ENSG00000150991,ENSG00000152137,ENSG00000158560,ENSG00000166484,ENSG00000173039,ENSG00000177606,ENSG00000184678,ENSG00000185386,ENSG00000185624,ENSG00000204389,ENSG00000269858	MAP4K4,DYNLL1,FZR1,CDKN1B,NCF2,PRDX5,TUBA4A,H3F3B,ETS1,UBC,HSPB8,DYNC1I1,MAPK7,RELA,JUN,HIST2H2BE,MAPK11,P4HB,HSPA1A,EGLN2
R-HSA-5621575	CD209 (DC-SIGN) signaling	3/247	17/7349	0.0179915498959284	0.200785696838561	0.180799294392768	5971/5894/5970	3	ENSG00000104856,ENSG00000132155,ENSG00000173039	RELB,RAF1,RELA
R-HSA-5675482	Regulation of necroptotic cell death	3/247	17/7349	0.0179915498959284	0.200785696838561	0.180799294392768	8717/329/7316	3	ENSG00000102871,ENSG00000110330,ENSG00000150991	TRADD,BIRC2,UBC
R-HSA-4791275	Signaling by WNT in cancer	4/247	31/7349	0.0192046109955656	0.208756615627122	0.187976780216336	5526/64840/22943/1487	4	ENSG00000068971,ENSG00000102312,ENSG00000107984,ENSG00000159692	PPP2R5B,PORCN,DKK1,CTBP1
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	4/247	31/7349	0.0192046109955656	0.208756615627122	0.187976780216336	1265/9049/375/1072	4	ENSG00000064666,ENSG00000110711,ENSG00000143761,ENSG00000172757	CNN2,AIP,ARF1,CFL1
R-HSA-6783589	Interleukin-6 family signaling	3/247	18/7349	0.0210645474930631	0.218280756878637	0.196552879236753	3589/23529/9021	3	ENSG00000095752,ENSG00000175505,ENSG00000184557	IL11,CLCF1,SOCS3
R-HSA-446203	Asparagine N-linked glycosylation	16/247	273/7349	0.0213022595346925	0.218280756878637	0.196552879236753	381/2530/8655/11316/10652/1294/7277/8818/10113/375/29926/7316/6396/1780/30815/6811	16	ENSG00000004059,ENSG00000033170,ENSG00000088986,ENSG00000105669,ENSG00000106636,ENSG00000114270,ENSG00000127824,ENSG00000136908,ENSG00000138073,ENSG00000143761,ENSG00000144591,ENSG00000150991,ENSG00000157020,ENSG00000158560,ENSG00000160408,ENSG00000162236	ARF5,FUT8,DYNLL1,COPE,YKT6,COL7A1,TUBA4A,DPM2,PREB,ARF1,GMPPA,UBC,SEC13,DYNC1I1,ST6GALNAC6,STX5
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	4/247	32/7349	0.0213847336488031	0.218280756878637	0.196552879236753	23645/5045/7316/5499	4	ENSG00000087074,ENSG00000140564,ENSG00000150991,ENSG00000172531	PPP1R15A,FURIN,UBC,PPP1CA
R-HSA-373752	Netrin-1 signaling	4/247	32/7349	0.0213847336488031	0.218280756878637	0.196552879236753	7220/5747/22885/5600	4	ENSG00000144935,ENSG00000169398,ENSG00000173210,ENSG00000185386	TRPC1,PTK2,ABLIM3,MAPK11
R-HSA-8875878	MET promotes cell motility	4/247	32/7349	0.0213847336488031	0.218280756878637	0.196552879236753	3918/3911/5747/3914	4	ENSG00000058085,ENSG00000130702,ENSG00000169398,ENSG00000196878	LAMC2,LAMA5,PTK2,LAMB3
R-HSA-977225	Amyloid fiber formation	5/247	48/7349	0.0217412623658721	0.219246224099217	0.19742224291648	3021/4240/5045/7316/8349	5	ENSG00000132475,ENSG00000140545,ENSG00000140564,ENSG00000150991,ENSG00000184678	H3F3B,MFGE8,FURIN,UBC,HIST2H2BE
R-HSA-109582	Hemostasis	22/247	416/7349	0.022725218053964	0.223182942605541	0.200967096655433	2769/10235/5526/2782/5216/2771/5768/5328/6385/7277/5880/5894/3021/388/7424/5152/3678/5747/1072/3932/3897/7114	22	ENSG00000060558,ENSG00000068831,ENSG00000068971,ENSG00000078369,ENSG00000108518,ENSG00000114353,ENSG00000116260,ENSG00000122861,ENSG00000124145,ENSG00000127824,ENSG00000128340,ENSG00000132155,ENSG00000132475,ENSG00000143878,ENSG00000150630,ENSG00000160191,ENSG00000161638,ENSG00000169398,ENSG00000172757,ENSG00000182866,ENSG00000198910,ENSG00000205542	GNA15,RASGRP2,PPP2R5B,GNB1,PFN1,GNAI2,QSOX1,PLAU,SDC4,TUBA4A,RAC2,RAF1,H3F3B,RHOB,VEGFC,PDE9A,ITGA5,PTK2,CFL1,LCK,L1CAM,TMSB4X
R-HSA-6806834	Signaling by MET	6/247	66/7349	0.0229285487328668	0.223182942605541	0.200967096655433	3918/3911/7316/5747/9146/3914	6	ENSG00000058085,ENSG00000130702,ENSG00000150991,ENSG00000169398,ENSG00000185359,ENSG00000196878	LAMC2,LAMA5,UBC,PTK2,HGS,LAMB3
R-HSA-388396	GPCR downstream signalling	19/247	345/7349	0.0229315807217163	0.223182942605541	0.200967096655433	23596/2769/25791/10235/2782/5744/23370/5924/2771/6385/5880/301/50649/388/389/1437/5598/136/5499	19	ENSG00000054277,ENSG00000060558,ENSG00000066248,ENSG00000068831,ENSG00000078369,ENSG00000087494,ENSG00000104880,ENSG00000113319,ENSG00000114353,ENSG00000124145,ENSG00000128340,ENSG00000135046,ENSG00000136002,ENSG00000143878,ENSG00000155366,ENSG00000164400,ENSG00000166484,ENSG00000170425,ENSG00000172531	OPN3,GNA15,NGEF,RASGRP2,GNB1,PTHLH,ARHGEF18,RASGRF2,GNAI2,SDC4,RAC2,ANXA1,ARHGEF4,RHOB,RHOC,CSF2,MAPK7,ADORA2B,PPP1CA
R-HSA-193704	p75 NTR receptor-mediated signalling	7/247	85/7349	0.0237551786250739	0.226981429207036	0.204387478227048	25791/4792/23370/5924/50649/7316/5970	7	ENSG00000066248,ENSG00000100906,ENSG00000104880,ENSG00000113319,ENSG00000136002,ENSG00000150991,ENSG00000173039	NGEF,NFKBIA,ARHGEF18,RASGRF2,ARHGEF4,UBC,RELA
R-HSA-168927	TICAM1, RIP1-mediated IKK complex recruitment 	3/247	19/7349	0.0244066052910791	0.226981429207036	0.204387478227048	329/7316/8517	3	ENSG00000110330,ENSG00000150991,ENSG00000269335	BIRC2,UBC,IKBKG
R-HSA-5213460	RIPK1-mediated regulated necrosis	3/247	19/7349	0.0244066052910791	0.226981429207036	0.204387478227048	8717/329/7316	3	ENSG00000102871,ENSG00000110330,ENSG00000150991	TRADD,BIRC2,UBC
R-HSA-5218859	Regulated Necrosis	3/247	19/7349	0.0244066052910791	0.226981429207036	0.204387478227048	8717/329/7316	3	ENSG00000102871,ENSG00000110330,ENSG00000150991	TRADD,BIRC2,UBC
R-HSA-9006934	Signaling by Receptor Tyrosine Kinases	19/247	348/7349	0.0248236036420921	0.228322596136605	0.205595144103389	3918/29924/3315/7072/4688/58513/3911/5045/7424/7316/5598/5747/6777/8877/3932/161/9146/5600/3914	19	ENSG00000058085,ENSG00000063245,ENSG00000106211,ENSG00000116001,ENSG00000116701,ENSG00000127527,ENSG00000130702,ENSG00000140564,ENSG00000150630,ENSG00000150991,ENSG00000166484,ENSG00000169398,ENSG00000173757,ENSG00000176170,ENSG00000182866,ENSG00000183020,ENSG00000185359,ENSG00000185386,ENSG00000196878	LAMC2,EPN1,HSPB1,TIA1,NCF2,EPS15L1,LAMA5,FURIN,VEGFC,UBC,MAPK7,PTK2,STAT5B,SPHK1,LCK,AP2A2,HGS,MAPK11,LAMB3
R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	5/247	50/7349	0.0254951838131922	0.231950748387411	0.208862146570316	8029/5045/161/5034/3931	5	ENSG00000107611,ENSG00000140564,ENSG00000183020,ENSG00000185624,ENSG00000213398	CUBN,FURIN,AP2A2,P4HB,LCAT
R-HSA-422356	Regulation of insulin secretion	5/247	51/7349	0.0275184435141441	0.239292391332864	0.215472995276779	2769/2782/2771/6812/784	5	ENSG00000060558,ENSG00000078369,ENSG00000114353,ENSG00000136854,ENSG00000167535	GNA15,GNB1,GNAI2,STXBP1,CACNB3
R-HSA-372790	Signaling by GPCR	20/247	376/7349	0.0276279881744113	0.239292391332864	0.215472995276779	23596/2769/25791/10235/2782/5744/23370/5924/2771/6385/5880/301/50649/388/90226/389/1437/5598/136/5499	20	ENSG00000054277,ENSG00000060558,ENSG00000066248,ENSG00000068831,ENSG00000078369,ENSG00000087494,ENSG00000104880,ENSG00000113319,ENSG00000114353,ENSG00000124145,ENSG00000128340,ENSG00000135046,ENSG00000136002,ENSG00000143878,ENSG00000145040,ENSG00000155366,ENSG00000164400,ENSG00000166484,ENSG00000170425,ENSG00000172531	OPN3,GNA15,NGEF,RASGRP2,GNB1,PTHLH,ARHGEF18,RASGRF2,GNAI2,SDC4,RAC2,ANXA1,ARHGEF4,RHOB,UCN2,RHOC,CSF2,MAPK7,ADORA2B,PPP1CA
R-HSA-199992	trans-Golgi Network Vesicle Budding	6/247	69/7349	0.0278585192897747	0.239292391332864	0.215472995276779	8907/8301/375/9146/8906/9179	6	ENSG00000072958,ENSG00000073921,ENSG00000143761,ENSG00000185359,ENSG00000213983,ENSG00000221838	AP1M1,PICALM,ARF1,HGS,AP1G2,AP4M1
R-HSA-421837	Clathrin derived vesicle budding	6/247	69/7349	0.0278585192897747	0.239292391332864	0.215472995276779	8907/8301/375/9146/8906/9179	6	ENSG00000072958,ENSG00000073921,ENSG00000143761,ENSG00000185359,ENSG00000213983,ENSG00000221838	AP1M1,PICALM,ARF1,HGS,AP1G2,AP4M1
R-HSA-392518	Signal amplification	3/247	20/7349	0.028017508184732	0.239292391332864	0.215472995276779	2769/2782/2771	3	ENSG00000060558,ENSG00000078369,ENSG00000114353	GNA15,GNB1,GNAI2
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	3/247	20/7349	0.028017508184732	0.239292391332864	0.215472995276779	4637/388/389	3	ENSG00000092841,ENSG00000143878,ENSG00000155366	MYL6,RHOB,RHOC
R-HSA-168638	NOD1/2 Signaling Pathway	4/247	35/7349	0.0288064588561933	0.241110060626338	0.217109732010888	329/7316/5600/8517	4	ENSG00000110330,ENSG00000150991,ENSG00000185386,ENSG00000269335	BIRC2,UBC,MAPK11,IKBKG
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	4/247	35/7349	0.0288064588561933	0.241110060626338	0.217109732010888	3918/1294/1515/3914	4	ENSG00000058085,ENSG00000114270,ENSG00000136943,ENSG00000196878	LAMC2,COL7A1,CTSV,LAMB3
R-HSA-1474290	Collagen formation	5/247	54/7349	0.0341893759930708	0.28055399711961	0.252627380918872	3918/1294/1515/5034/3914	5	ENSG00000058085,ENSG00000114270,ENSG00000136943,ENSG00000185624,ENSG00000196878	LAMC2,COL7A1,CTSV,P4HB,LAMB3
R-HSA-5625740	RHO GTPases activate PKNs	5/247	54/7349	0.0341893759930708	0.28055399711961	0.252627380918872	4637/3021/388/389/8349	5	ENSG00000092841,ENSG00000132475,ENSG00000143878,ENSG00000155366,ENSG00000184678	MYL6,H3F3B,RHOB,RHOC,HIST2H2BE
R-HSA-2871837	FCERI mediated NF-kB activation	6/247	73/7349	0.0354543854007536	0.288109908547871	0.259431169616143	10235/997/4792/7316/5970/8517	6	ENSG00000068831,ENSG00000099804,ENSG00000100906,ENSG00000150991,ENSG00000173039,ENSG00000269335	RASGRP2,CDC34,NFKBIA,UBC,RELA,IKBKG
R-HSA-5223345	Miscellaneous transport and binding events	3/247	22/7349	0.0360401208902975	0.290053665242106	0.261181442889201	118/80131/84230	3	ENSG00000087274,ENSG00000171017,ENSG00000171488	ADD1,LRRC8E,LRRC8C
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	3/247	23/7349	0.0404467952013165	0.3111159247462	0.28014714471267	7316/5600/8517	3	ENSG00000150991,ENSG00000185386,ENSG00000269335	UBC,MAPK11,IKBKG
R-HSA-937041	IKK complex recruitment mediated by RIP1	3/247	23/7349	0.0404467952013165	0.3111159247462	0.28014714471267	329/7316/8517	3	ENSG00000110330,ENSG00000150991,ENSG00000269335	BIRC2,UBC,IKBKG
R-HSA-177929	Signaling by EGFR	4/247	39/7349	0.0408111758965105	0.3111159247462	0.28014714471267	29924/58513/7316/9146	4	ENSG00000063245,ENSG00000127527,ENSG00000150991,ENSG00000185359	EPN1,EPS15L1,UBC,HGS
R-HSA-5675221	Negative regulation of MAPK pathway	4/247	39/7349	0.0408111758965105	0.3111159247462	0.28014714471267	5526/5894/11221/7316	4	ENSG00000068971,ENSG00000132155,ENSG00000143507,ENSG00000150991	PPP2R5B,RAF1,DUSP10,UBC
R-HSA-202424	Downstream TCR signaling	6/247	76/7349	0.0419498369585106	0.3111159247462	0.28014714471267	997/4792/7316/5970/3932/8517	6	ENSG00000099804,ENSG00000100906,ENSG00000150991,ENSG00000173039,ENSG00000182866,ENSG00000269335	CDC34,NFKBIA,UBC,RELA,LCK,IKBKG
R-HSA-2586552	Signaling by Leptin	2/247	10/7349	0.0423742119726008	0.3111159247462	0.28014714471267	6777/9021	2	ENSG00000173757,ENSG00000184557	STAT5B,SOCS3
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production 	2/247	10/7349	0.0423742119726008	0.3111159247462	0.28014714471267	4791/5970	2	ENSG00000077150,ENSG00000173039	NFKB2,RELA
R-HSA-450341	Activation of the AP-1 family of transcription factors	2/247	10/7349	0.0423742119726008	0.3111159247462	0.28014714471267	3725/5600	2	ENSG00000177606,ENSG00000185386	JUN,MAPK11
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	2/247	10/7349	0.0423742119726008	0.3111159247462	0.28014714471267	4688/5880	2	ENSG00000116701,ENSG00000128340	NCF2,RAC2
R-HSA-73614	Pyrimidine salvage	2/247	10/7349	0.0423742119726008	0.3111159247462	0.28014714471267	1890/7378	2	ENSG00000025708,ENSG00000183696	TYMP,UPP1
R-HSA-5607764	CLEC7A (Dectin-1) signaling	7/247	97/7349	0.0442592386724905	0.322130284946735	0.290065124846711	4791/997/4792/5971/7316/5970/8517	7	ENSG00000077150,ENSG00000099804,ENSG00000100906,ENSG00000104856,ENSG00000150991,ENSG00000173039,ENSG00000269335	NFKB2,CDC34,NFKBIA,RELB,UBC,RELA,IKBKG
R-HSA-400685	Sema4D in semaphorin signaling	3/247	24/7349	0.0451124059537873	0.325509342959655	0.293107828157094	4637/388/389	3	ENSG00000092841,ENSG00000143878,ENSG00000155366	MYL6,RHOB,RHOC
R-HSA-397014	Muscle contraction	7/247	99/7349	0.048523736751136	0.339252972691127	0.30548340369345	4637/7139/10174/301/7220/1193/784	7	ENSG00000092841,ENSG00000118194,ENSG00000120896,ENSG00000135046,ENSG00000144935,ENSG00000155962,ENSG00000167535	MYL6,TNNT2,SORBS3,ANXA1,TRPC1,CLIC2,CACNB3
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	8/247	120/7349	0.048603360969284	0.339252972691127	0.30548340369345	10235/4214/997/4792/7316/5970/3725/8517	8	ENSG00000068831,ENSG00000095015,ENSG00000099804,ENSG00000100906,ENSG00000150991,ENSG00000173039,ENSG00000177606,ENSG00000269335	RASGRP2,MAP3K1,CDC34,NFKBIA,UBC,RELA,JUN,IKBKG
R-HSA-446652	Interleukin-1 family signaling	8/247	120/7349	0.048603360969284	0.339252972691127	0.30548340369345	25930/4791/4792/9173/7316/5970/59307/8517	8	ENSG00000076201,ENSG00000077150,ENSG00000100906,ENSG00000115602,ENSG00000150991,ENSG00000173039,ENSG00000185187,ENSG00000269335	PTPN23,NFKB2,NFKBIA,IL1RL1,UBC,RELA,SIGIRR,IKBKG
R-HSA-2682334	EPH-Ephrin signaling	6/247	79/7349	0.049150376124626	0.339252972691127	0.30548340369345	25791/4637/5747/1072/161/10552	6	ENSG00000066248,ENSG00000092841,ENSG00000169398,ENSG00000172757,ENSG00000183020,ENSG00000241685	NGEF,MYL6,PTK2,CFL1,AP2A2,ARPC1A
R-HSA-112316	Neuronal System	10/247	164/7349	0.0493072082023066	0.339252972691127	0.30548340369345	9066/2782/5924/2771/5894/6812/10211/784/81858/161	10	ENSG00000011347,ENSG00000078369,ENSG00000113319,ENSG00000114353,ENSG00000132155,ENSG00000136854,ENSG00000137312,ENSG00000167535,ENSG00000179526,ENSG00000183020	SYT7,GNB1,RASGRF2,GNAI2,RAF1,STXBP1,FLOT1,CACNB3,SHARPIN,AP2A2
R-HSA-114604	GPVI-mediated activation cascade	3/247	25/7349	0.0500326203733834	0.339252972691127	0.30548340369345	5880/388/3932	3	ENSG00000128340,ENSG00000143878,ENSG00000182866	RAC2,RHOB,LCK
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	2/247	11/7349	0.0506650198164765	0.339252972691127	0.30548340369345	2782/2771	2	ENSG00000078369,ENSG00000114353	GNB1,GNAI2
R-HSA-399956	CRMPs in Sema3A signaling	2/247	11/7349	0.0506650198164765	0.339252972691127	0.30548340369345	1808/55558	2	ENSG00000092964,ENSG00000130827	DPYSL2,PLXNA3
R-HSA-4641265	Repression of WNT target genes	2/247	11/7349	0.0506650198164765	0.339252972691127	0.30548340369345	7090/1487	2	ENSG00000140332,ENSG00000159692	TLE3,CTBP1
R-HSA-3000171	Non-integrin membrane-ECM interactions	4/247	42/7349	0.0514165713976132	0.341552938569859	0.307554428744286	3918/6385/3911/3914	4	ENSG00000058085,ENSG00000124145,ENSG00000130702,ENSG00000196878	LAMC2,SDC4,LAMA5,LAMB3
R-HSA-5621481	C-type lectin receptors (CLRs)	8/247	122/7349	0.0526560482835362	0.347032381207243	0.312488442362304	4791/997/4792/5971/5894/7316/5970/8517	8	ENSG00000077150,ENSG00000099804,ENSG00000100906,ENSG00000104856,ENSG00000132155,ENSG00000150991,ENSG00000173039,ENSG00000269335	NFKB2,CDC34,NFKBIA,RELB,RAF1,UBC,RELA,IKBKG
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	3/247	26/7349	0.0552025082480807	0.360972651590965	0.325041084750212	23645/7316/5499	3	ENSG00000087074,ENSG00000150991,ENSG00000172531	PPP1R15A,UBC,PPP1CA
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	4/247	44/7349	0.0592454996461534	0.375348601239877	0.337986038467901	329/7316/5600/8517	4	ENSG00000110330,ENSG00000150991,ENSG00000185386,ENSG00000269335	BIRC2,UBC,MAPK11,IKBKG
R-HSA-6794362	Protein-protein interactions at synapses	4/247	44/7349	0.0592454996461534	0.375348601239877	0.337986038467901	9066/6812/10211/81858	4	ENSG00000011347,ENSG00000136854,ENSG00000137312,ENSG00000179526	SYT7,STXBP1,FLOT1,SHARPIN
R-HSA-202040	G-protein activation	2/247	12/7349	0.0594804150250172	0.375348601239877	0.337986038467901	2782/2771	2	ENSG00000078369,ENSG00000114353	GNB1,GNAI2
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	2/247	12/7349	0.0594804150250172	0.375348601239877	0.337986038467901	3589/23529	2	ENSG00000095752,ENSG00000175505	IL11,CLCF1
R-HSA-450294	MAP kinase activation	5/247	63/7349	0.0598100061442943	0.375348601239877	0.337986038467901	7316/5598/3725/5600/8517	5	ENSG00000150991,ENSG00000166484,ENSG00000177606,ENSG00000185386,ENSG00000269335	UBC,MAPK7,JUN,MAPK11,IKBKG
R-HSA-201681	TCF dependent signaling in response to WNT	10/247	170/7349	0.060091651811402	0.375348601239877	0.337986038467901	5526/1855/22943/6659/3021/7090/7316/1487/56998/8349	10	ENSG00000068971,ENSG00000107404,ENSG00000107984,ENSG00000124766,ENSG00000132475,ENSG00000140332,ENSG00000150991,ENSG00000159692,ENSG00000178585,ENSG00000184678	PPP2R5B,DVL1,DKK1,SOX4,H3F3B,TLE3,UBC,CTBP1,CTNNBIP1,HIST2H2BE
R-HSA-445355	Smooth Muscle Contraction	3/247	27/7349	0.0606166061979733	0.375822958427435	0.338413177682253	4637/10174/301	3	ENSG00000092841,ENSG00000120896,ENSG00000135046	MYL6,SORBS3,ANXA1
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	5/247	64/7349	0.0631845234932734	0.386025154480802	0.34759983727379	4791/4792/7316/5970/8517	5	ENSG00000077150,ENSG00000100906,ENSG00000150991,ENSG00000173039,ENSG00000269335	NFKB2,NFKBIA,UBC,RELA,IKBKG
R-HSA-204005	COPII-mediated vesicle transport	5/247	64/7349	0.0631845234932734	0.386025154480802	0.34759983727379	10652/1294/10113/6396/6811	5	ENSG00000106636,ENSG00000114270,ENSG00000138073,ENSG00000157020,ENSG00000162236	YKT6,COL7A1,PREB,SEC13,STX5
R-HSA-4086400	PCP/CE pathway	6/247	85/7349	0.0657112426896011	0.391602589295981	0.352622088833456	1855/5216/5880/7316/23513/161	6	ENSG00000107404,ENSG00000108518,ENSG00000128340,ENSG00000150991,ENSG00000180900,ENSG00000183020	DVL1,PFN1,RAC2,UBC,SCRIB,AP2A2
R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR)	4/247	46/7349	0.0676722207456592	0.391602589295981	0.352622088833456	8655/7277/1780/3303	4	ENSG00000088986,ENSG00000127824,ENSG00000158560,ENSG00000204389	DYNLL1,TUBA4A,DYNC1I1,HSPA1A
R-HSA-174490	Membrane binding and targetting of GAG proteins	2/247	13/7349	0.0687760819910505	0.391602589295981	0.352622088833456	7316/51271	2	ENSG00000150991,ENSG00000165006	UBC,UBAP1
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	2/247	13/7349	0.0687760819910505	0.391602589295981	0.352622088833456	7316/51271	2	ENSG00000150991,ENSG00000165006	UBC,UBAP1
R-HSA-392517	Rap1 signalling	2/247	13/7349	0.0687760819910505	0.391602589295981	0.352622088833456	10235/5894	2	ENSG00000068831,ENSG00000132155	RASGRP2,RAF1
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	2/247	13/7349	0.0687760819910505	0.391602589295981	0.352622088833456	55558/23396	2	ENSG00000130827,ENSG00000186111	PLXNA3,PIP5K1C
R-HSA-416700	Other semaphorin interactions	2/247	13/7349	0.0687760819910505	0.391602589295981	0.352622088833456	8482/5365	2	ENSG00000138623,ENSG00000198753	SEMA7A,PLXNB3
R-HSA-418885	DCC mediated attractive signaling	2/247	13/7349	0.0687760819910505	0.391602589295981	0.352622088833456	5747/22885	2	ENSG00000169398,ENSG00000173210	PTK2,ABLIM3
R-HSA-428930	Thromboxane signalling through TP receptor	2/247	13/7349	0.0687760819910505	0.391602589295981	0.352622088833456	2769/2782	2	ENSG00000060558,ENSG00000078369	GNA15,GNB1
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	2/247	13/7349	0.0687760819910505	0.391602589295981	0.352622088833456	7316/9146	2	ENSG00000150991,ENSG00000185359	UBC,HGS
R-HSA-202403	TCR signaling	6/247	87/7349	0.0718764696546342	0.399948915334647	0.360137613506392	997/4792/7316/5970/3932/8517	6	ENSG00000099804,ENSG00000100906,ENSG00000150991,ENSG00000173039,ENSG00000182866,ENSG00000269335	CDC34,NFKBIA,UBC,RELA,LCK,IKBKG
R-HSA-373760	L1CAM interactions	6/247	87/7349	0.0718764696546342	0.399948915334647	0.360137613506392	1808/7277/5962/3678/161/3897	6	ENSG00000092964,ENSG00000127824,ENSG00000137710,ENSG00000161638,ENSG00000183020,ENSG00000198910	DPYSL2,TUBA4A,RDX,ITGA5,AP2A2,L1CAM
R-HSA-451927	Interleukin-2 family signaling	3/247	29/7349	0.0721532690747094	0.399948915334647	0.360137613506392	1437/6777/3932	3	ENSG00000164400,ENSG00000173757,ENSG00000182866	CSF2,STAT5B,LCK
R-HSA-6794361	Neurexins and neuroligins	3/247	29/7349	0.0721532690747094	0.399948915334647	0.360137613506392	9066/6812/81858	3	ENSG00000011347,ENSG00000136854,ENSG00000179526	SYT7,STXBP1,SHARPIN
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	5/247	67/7349	0.0739387351391062	0.400688591023036	0.360803661161408	25791/23370/5924/50649/7316	5	ENSG00000066248,ENSG00000104880,ENSG00000113319,ENSG00000136002,ENSG00000150991	NGEF,ARHGEF18,RASGRF2,ARHGEF4,UBC
R-HSA-448424	Interleukin-17 signaling	5/247	67/7349	0.0739387351391062	0.400688591023036	0.360803661161408	7316/5598/3725/5600/8517	5	ENSG00000150991,ENSG00000166484,ENSG00000177606,ENSG00000185386,ENSG00000269335	UBC,MAPK7,JUN,MAPK11,IKBKG
R-HSA-2559580	Oxidative Stress Induced Senescence	6/247	88/7349	0.0750798549538178	0.400688591023036	0.360803661161408	9448/3021/7316/3725/8349/5600	6	ENSG00000071054,ENSG00000132475,ENSG00000150991,ENSG00000177606,ENSG00000184678,ENSG00000185386	MAP4K4,H3F3B,UBC,JUN,HIST2H2BE,MAPK11
R-HSA-112315	Transmission across Chemical Synapses	7/247	110/7349	0.0765648972457779	0.400688591023036	0.360803661161408	2782/5924/2771/5894/6812/784/161	7	ENSG00000078369,ENSG00000113319,ENSG00000114353,ENSG00000132155,ENSG00000136854,ENSG00000167535,ENSG00000183020	GNB1,RASGRF2,GNAI2,RAF1,STXBP1,CACNB3,AP2A2
R-HSA-983712	Ion channel transport	7/247	110/7349	0.0765648972457779	0.400688591023036	0.360803661161408	59341/65266/5894/7220/7316/1193/162514	7	ENSG00000111199,ENSG00000126562,ENSG00000132155,ENSG00000144935,ENSG00000150991,ENSG00000155962,ENSG00000167723	TRPV4,WNK4,RAF1,TRPC1,UBC,CLIC2,TRPV3
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	4/247	48/7349	0.0766847748055568	0.400688591023036	0.360803661161408	8897/375/55361/23396	4	ENSG00000100330,ENSG00000143761,ENSG00000155252,ENSG00000186111	MTMR3,ARF1,PI4K2A,PIP5K1C
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	4/247	48/7349	0.0766847748055568	0.400688591023036	0.360803661161408	4650/5747/1072/10552	4	ENSG00000099331,ENSG00000169398,ENSG00000172757,ENSG00000241685	MYO9B,PTK2,CFL1,ARPC1A
R-HSA-3299685	Detoxification of Reactive Oxygen Species	3/247	30/7349	0.0782627617278483	0.400688591023036	0.360803661161408	4688/25824/5034	3	ENSG00000116701,ENSG00000126432,ENSG00000185624	NCF2,PRDX5,P4HB
R-HSA-5694530	Cargo concentration in the ER	3/247	30/7349	0.0782627617278483	0.400688591023036	0.360803661161408	1294/10113/6811	3	ENSG00000114270,ENSG00000138073,ENSG00000162236	COL7A1,PREB,STX5
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	3/247	30/7349	0.0782627617278483	0.400688591023036	0.360803661161408	7316/51271/9146	3	ENSG00000150991,ENSG00000165006,ENSG00000185359	UBC,UBAP1,HGS
R-HSA-399954	Sema3A PAK dependent Axon repulsion	2/247	14/7349	0.0785100704035578	0.400688591023036	0.360803661161408	55558/1072	2	ENSG00000130827,ENSG00000172757	PLXNA3,CFL1
R-HSA-937039	IRAK1 recruits IKK complex	2/247	14/7349	0.0785100704035578	0.400688591023036	0.360803661161408	7316/8517	2	ENSG00000150991,ENSG00000269335	UBC,IKBKG
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	2/247	14/7349	0.0785100704035578	0.400688591023036	0.360803661161408	7316/8517	2	ENSG00000150991,ENSG00000269335	UBC,IKBKG
R-HSA-114608	Platelet degranulation 	6/247	90/7349	0.0817270822056391	0.414579198824969	0.373311584428948	5216/5768/7277/7424/1072/7114	6	ENSG00000108518,ENSG00000116260,ENSG00000127824,ENSG00000150630,ENSG00000172757,ENSG00000205542	PFN1,QSOX1,TUBA4A,VEGFC,CFL1,TMSB4X
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	3/247	31/7349	0.0845904207348786	0.423965162605349	0.38176326029734	5598/3725/5600	3	ENSG00000166484,ENSG00000177606,ENSG00000185386	MAPK7,JUN,MAPK11
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	3/247	31/7349	0.0845904207348786	0.423965162605349	0.38176326029734	3081/120103/125061	3	ENSG00000113924,ENSG00000180773,ENSG00000183077	HGD,SLC36A4,AFMID
R-HSA-400253	Circadian Clock	5/247	70/7349	0.0856269895486529	0.424081599125577	0.381868106613737	56938/7316/25819/4783/5499	5	ENSG00000029153,ENSG00000150991,ENSG00000151014,ENSG00000165030,ENSG00000172531	ARNTL2,UBC,CCRN4L,NFIL3,PPP1CA
R-HSA-8957275	Post-translational protein phosphorylation	5/247	70/7349	0.0856269895486529	0.424081599125577	0.381868106613737	5768/4240/3486/4241/5034	5	ENSG00000116260,ENSG00000140545,ENSG00000146674,ENSG00000163975,ENSG00000185624	QSOX1,MFGE8,IGFBP3,MFI2,P4HB
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	2/247	15/7349	0.088642687359412	0.431603514653704	0.388641283395651	375/55361	2	ENSG00000143761,ENSG00000155252	ARF1,PI4K2A
R-HSA-5683826	Surfactant metabolism	2/247	15/7349	0.088642687359412	0.431603514653704	0.388641283395651	29995/136	2	ENSG00000071282,ENSG00000170425	LMCD1,ADORA2B
R-HSA-9006936	Signaling by TGF-beta family members	6/247	92/7349	0.0886927174676667	0.431603514653704	0.388641283395651	23645/23370/3624/5045/7316/5499	6	ENSG00000087074,ENSG00000104880,ENSG00000122641,ENSG00000140564,ENSG00000150991,ENSG00000172531	PPP1R15A,ARHGEF18,INHBA,FURIN,UBC,PPP1CA
R-HSA-112314	Neurotransmitter receptors and postsynaptic signal transmission	5/247	71/7349	0.0897269821297649	0.434040926229647	0.390836072666073	2782/5924/2771/5894/161	5	ENSG00000078369,ENSG00000113319,ENSG00000114353,ENSG00000132155,ENSG00000183020	GNB1,RASGRF2,GNAI2,RAF1,AP2A2
R-HSA-1566948	Elastic fibre formation	3/247	32/7349	0.0911289400886106	0.434040926229647	0.390836072666073	5045/3678/4054	3	ENSG00000140564,ENSG00000161638,ENSG00000168056	FURIN,ITGA5,LTBP3
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	3/247	32/7349	0.0911289400886106	0.434040926229647	0.390836072666073	3423/6385/55454	3	ENSG00000010404,ENSG00000124145,ENSG00000169826	IDS,SDC4,CSGALNACT2
R-HSA-193648	NRAGE signals death through JNK	4/247	51/7349	0.0912678650136415	0.434040926229647	0.390836072666073	25791/23370/5924/50649	4	ENSG00000066248,ENSG00000104880,ENSG00000113319,ENSG00000136002	NGEF,ARHGEF18,RASGRF2,ARHGEF4
R-HSA-194138	Signaling by VEGF	6/247	93/7349	0.0922938774264743	0.436440539016717	0.392996825675621	3315/4688/7424/5747/8877/5600	6	ENSG00000106211,ENSG00000116701,ENSG00000150630,ENSG00000169398,ENSG00000176170,ENSG00000185386	HSPB1,NCF2,VEGFC,PTK2,SPHK1,MAPK11
R-HSA-170834	Signaling by TGF-beta Receptor Complex	5/247	72/7349	0.0939272829624727	0.439201876198825	0.395483296684096	23645/23370/5045/7316/5499	5	ENSG00000087074,ENSG00000104880,ENSG00000140564,ENSG00000150991,ENSG00000172531	PPP1R15A,ARHGEF18,FURIN,UBC,PPP1CA
R-HSA-390466	Chaperonin-mediated protein folding	5/247	72/7349	0.0939272829624727	0.439201876198825	0.395483296684096	2782/6468/2771/7277/8877	5	ENSG00000078369,ENSG00000107829,ENSG00000114353,ENSG00000127824,ENSG00000176170	GNB1,FBXW4,GNAI2,TUBA4A,SPHK1
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	6/247	94/7349	0.09597324426916	0.446113773042588	0.401707176631445	5216/5768/7277/7424/1072/7114	6	ENSG00000108518,ENSG00000116260,ENSG00000127824,ENSG00000150630,ENSG00000172757,ENSG00000205542	PFN1,QSOX1,TUBA4A,VEGFC,CFL1,TMSB4X
R-HSA-1442490	Collagen degradation	3/247	33/7349	0.0978707847264233	0.446113773042588	0.401707176631445	1294/1509/5045	3	ENSG00000114270,ENSG00000117984,ENSG00000140564	COL7A1,CTSD,FURIN
R-HSA-2024096	HS-GAG degradation	2/247	16/7349	0.0991363940094641	0.446113773042588	0.401707176631445	3423/6385	2	ENSG00000010404,ENSG00000124145	IDS,SDC4
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	2/247	16/7349	0.0991363940094641	0.446113773042588	0.401707176631445	23370/7316	2	ENSG00000104880,ENSG00000150991	ARHGEF18,UBC
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	2/247	16/7349	0.0991363940094641	0.446113773042588	0.401707176631445	2769/2782	2	ENSG00000060558,ENSG00000078369	GNA15,GNB1
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	2/247	16/7349	0.0991363940094641	0.446113773042588	0.401707176631445	7316/8517	2	ENSG00000150991,ENSG00000269335	UBC,IKBKG
R-HSA-8963899	Plasma lipoprotein remodeling	2/247	16/7349	0.0991363940094641	0.446113773042588	0.401707176631445	5045/3931	2	ENSG00000140564,ENSG00000213398	FURIN,LCAT
R-HSA-5689896	Ovarian tumor domain proteases	3/247	34/7349	0.104808229541121	0.469114909764269	0.422418757959148	55593/7316/8517	3	ENSG00000068308,ENSG00000150991,ENSG00000269335	OTUD5,UBC,IKBKG
R-HSA-163685	Integration of energy metabolism	5/247	75/7349	0.107118269283492	0.47690420952278	0.429432703286563	2769/2782/2771/6812/784	5	ENSG00000060558,ENSG00000078369,ENSG00000114353,ENSG00000136854,ENSG00000167535	GNA15,GNB1,GNAI2,STXBP1,CACNB3
R-HSA-5689880	Ub-specific processing proteases	9/247	167/7349	0.109345003890428	0.48184778214132	0.433884187905659	79594/4792/23770/329/7316/10474/8349/9146/8517	9	ENSG00000090432,ENSG00000100906,ENSG00000105701,ENSG00000110330,ENSG00000150991,ENSG00000171148,ENSG00000184678,ENSG00000185359,ENSG00000269335	MUL1,NFKBIA,FKBP8,BIRC2,UBC,TADA3,HIST2H2BE,HGS,IKBKG
R-HSA-163560	Triglyceride catabolism	2/247	17/7349	0.109955706557936	0.48184778214132	0.433884187905659	10226/5499	2	ENSG00000105355,ENSG00000172531	PLIN3,PPP1CA
R-HSA-389513	CTLA4 inhibitory signaling	2/247	17/7349	0.109955706557936	0.48184778214132	0.433884187905659	5526/3932	2	ENSG00000068971,ENSG00000182866	PPP2R5B,LCK
R-HSA-111465	Apoptotic cleavage of cellular proteins	3/247	35/7349	0.111933395542833	0.487959646194537	0.439387671100156	118/329/5747	3	ENSG00000087274,ENSG00000110330,ENSG00000169398	ADD1,BIRC2,PTK2
R-HSA-3858494	Beta-catenin independent WNT signaling	7/247	122/7349	0.11606036835442	0.497137055770554	0.447651552451382	2782/1855/5216/5880/7316/23513/161	7	ENSG00000078369,ENSG00000107404,ENSG00000108518,ENSG00000128340,ENSG00000150991,ENSG00000180900,ENSG00000183020	GNB1,DVL1,PFN1,RAC2,UBC,SCRIB,AP2A2
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	5/247	77/7349	0.116390696626533	0.497137055770554	0.447651552451382	27175/8655/7277/5116/9814	5	ENSG00000037042,ENSG00000088986,ENSG00000127824,ENSG00000160299,ENSG00000198089	TUBG2,DYNLL1,TUBA4A,PCNT,SFI1
R-HSA-380287	Centrosome maturation	5/247	77/7349	0.116390696626533	0.497137055770554	0.447651552451382	27175/8655/7277/5116/9814	5	ENSG00000037042,ENSG00000088986,ENSG00000127824,ENSG00000160299,ENSG00000198089	TUBG2,DYNLL1,TUBA4A,PCNT,SFI1
R-HSA-1912420	Pre-NOTCH Processing in Golgi	2/247	18/7349	0.121067101441045	0.497137055770554	0.447651552451382	3955/5045	2	ENSG00000106003,ENSG00000140564	LFNG,FURIN
R-HSA-445144	Signal transduction by L1	2/247	18/7349	0.121067101441045	0.497137055770554	0.447651552451382	3678/3897	2	ENSG00000161638,ENSG00000198910	ITGA5,L1CAM
R-HSA-6807004	Negative regulation of MET activity	2/247	18/7349	0.121067101441045	0.497137055770554	0.447651552451382	7316/9146	2	ENSG00000150991,ENSG00000185359	UBC,HGS
R-HSA-8876384	Listeria monocytogenes entry into host cells	2/247	18/7349	0.121067101441045	0.497137055770554	0.447651552451382	7316/9146	2	ENSG00000150991,ENSG00000185359	UBC,HGS
R-HSA-9008059	Interleukin-37 signaling	2/247	18/7349	0.121067101441045	0.497137055770554	0.447651552451382	25930/59307	2	ENSG00000076201,ENSG00000185187	PTPN23,SIGIRR
R-HSA-977444	GABA B receptor activation	2/247	18/7349	0.121067101441045	0.497137055770554	0.447651552451382	2782/2771	2	ENSG00000078369,ENSG00000114353	GNB1,GNAI2
R-HSA-991365	Activation of GABAB receptors	2/247	18/7349	0.121067101441045	0.497137055770554	0.447651552451382	2782/2771	2	ENSG00000078369,ENSG00000114353	GNB1,GNAI2
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	5/247	78/7349	0.121166020761282	0.497137055770554	0.447651552451382	5768/4240/3486/4241/5034	5	ENSG00000116260,ENSG00000140545,ENSG00000146674,ENSG00000163975,ENSG00000185624	QSOX1,MFGE8,IGFBP3,MFI2,P4HB
R-HSA-391251	Protein folding	5/247	78/7349	0.121166020761282	0.497137055770554	0.447651552451382	2782/6468/2771/7277/8877	5	ENSG00000078369,ENSG00000107829,ENSG00000114353,ENSG00000127824,ENSG00000176170	GNB1,FBXW4,GNAI2,TUBA4A,SPHK1
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	3/247	37/7349	0.126714804053739	0.517367273136486	0.465868034415801	7316/1437/6777	3	ENSG00000150991,ENSG00000164400,ENSG00000173757	UBC,CSF2,STAT5B
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	4/247	58/7349	0.129905215758498	0.527818764999336	0.475279174670848	4791/5971/7316/5970	4	ENSG00000077150,ENSG00000104856,ENSG00000150991,ENSG00000173039	NFKB2,RELB,UBC,RELA
R-HSA-354192	Integrin alphaIIb beta3 signaling	2/247	19/7349	0.132438924517511	0.530389377134721	0.477593905588204	10235/5747	2	ENSG00000068831,ENSG00000169398	RASGRP2,PTK2
R-HSA-9006921	Integrin signaling	2/247	19/7349	0.132438924517511	0.530389377134721	0.477593905588204	10235/5747	2	ENSG00000068831,ENSG00000169398	RASGRP2,PTK2
R-HSA-982772	Growth hormone receptor signaling	2/247	19/7349	0.132438924517511	0.530389377134721	0.477593905588204	6777/9021	2	ENSG00000173757,ENSG00000184557	STAT5B,SOCS3
R-HSA-382551	Transport of small molecules	21/247	484/7349	0.135774440490586	0.541158127098192	0.487290723765711	2782/118/8029/59341/6560/65266/5894/5045/284111/7220/55630/7316/1193/10999/162514/80131/84230/120103/161/5034/3931	21	ENSG00000078369,ENSG00000087274,ENSG00000107611,ENSG00000111199,ENSG00000124067,ENSG00000126562,ENSG00000132155,ENSG00000140564,ENSG00000141485,ENSG00000144935,ENSG00000147804,ENSG00000150991,ENSG00000155962,ENSG00000167114,ENSG00000167723,ENSG00000171017,ENSG00000171488,ENSG00000180773,ENSG00000183020,ENSG00000185624,ENSG00000213398	GNB1,ADD1,CUBN,TRPV4,SLC12A4,WNK4,RAF1,FURIN,SLC13A5,TRPC1,SLC39A4,UBC,CLIC2,SLC27A4,TRPV3,LRRC8E,LRRC8C,SLC36A4,AP2A2,P4HB,LCAT
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	5/247	82/7349	0.141156019975089	0.555979638193223	0.500636887312265	89781/11021/116442/51112/2664	5	ENSG00000100099,ENSG00000111737,ENSG00000155961,ENSG00000171853,ENSG00000203879	HPS4,RAB35,RAB39B,TRAPPC12,GDI1
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	4/247	60/7349	0.142021123754805	0.555979638193223	0.500636887312265	5526/9173/3932/23396	4	ENSG00000068971,ENSG00000115602,ENSG00000182866,ENSG00000186111	PPP2R5B,IL1RL1,LCK,PIP5K1C
R-HSA-373080	Class B/2 (Secretin family receptors)	3/247	39/7349	0.142150110601374	0.555979638193223	0.500636887312265	2782/5744/90226	3	ENSG00000078369,ENSG00000087494,ENSG00000145040	GNB1,PTHLH,UCN2
R-HSA-3928662	EPHB-mediated forward signaling	3/247	39/7349	0.142150110601374	0.555979638193223	0.500636887312265	5747/1072/10552	3	ENSG00000169398,ENSG00000172757,ENSG00000241685	PTK2,CFL1,ARPC1A
R-HSA-8956321	Nucleotide salvage	2/247	20/7349	0.144041304110042	0.558160053426413	0.502600261904436	1890/7378	2	ENSG00000025708,ENSG00000183696	TYMP,UPP1
R-HSA-977443	GABA receptor activation	2/247	20/7349	0.144041304110042	0.558160053426413	0.502600261904436	2782/2771	2	ENSG00000078369,ENSG00000114353	GNB1,GNAI2
R-HSA-418555	G alpha (s) signalling events	4/247	61/7349	0.148241680696694	0.571789339830107	0.514872875958444	2782/5744/2771/136	4	ENSG00000078369,ENSG00000087494,ENSG00000114353,ENSG00000170425	GNB1,PTHLH,GNAI2,ADORA2B
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	9/247	181/7349	0.155393988719878	0.589393242365607	0.530724469010595	381/8655/10226/11316/10652/7277/375/1780/6811	9	ENSG00000004059,ENSG00000088986,ENSG00000105355,ENSG00000105669,ENSG00000106636,ENSG00000127824,ENSG00000143761,ENSG00000158560,ENSG00000162236	ARF5,DYNLL1,PLIN3,COPE,YKT6,TUBA4A,ARF1,DYNC1I1,STX5
R-HSA-3371571	HSF1-dependent transactivation	2/247	21/7349	0.15584606774312	0.589393242365607	0.530724469010595	26353/3303	2	ENSG00000152137,ENSG00000204389	HSPB8,HSPA1A
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	2/247	21/7349	0.15584606774312	0.589393242365607	0.530724469010595	2769/2782	2	ENSG00000060558,ENSG00000078369	GNA15,GNB1
R-HSA-1500931	Cell-Cell communication	5/247	85/7349	0.157030696592032	0.589393242365607	0.530724469010595	8935/3918/5817/5747/3914	5	ENSG00000005020,ENSG00000058085,ENSG00000073008,ENSG00000169398,ENSG00000196878	SKAP2,LAMC2,PVR,PTK2,LAMB3
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	5/247	85/7349	0.157030696592032	0.589393242365607	0.530724469010595	8655/7277/7316/5116/9814	5	ENSG00000088986,ENSG00000127824,ENSG00000150991,ENSG00000160299,ENSG00000198089	DYNLL1,TUBA4A,UBC,PCNT,SFI1
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	5/247	85/7349	0.157030696592032	0.589393242365607	0.530724469010595	27175/8655/7277/5116/9814	5	ENSG00000037042,ENSG00000088986,ENSG00000127824,ENSG00000160299,ENSG00000198089	TUBG2,DYNLL1,TUBA4A,PCNT,SFI1
R-HSA-6811438	Intra-Golgi traffic	3/247	41/7349	0.158173845039728	0.591033519188627	0.532201471092319	10652/375/6811	3	ENSG00000106636,ENSG00000143761,ENSG00000162236	YKT6,ARF1,STX5
R-HSA-1632852	Macroautophagy	4/247	63/7349	0.160989979002987	0.59888272189111	0.53926935656673	8655/8897/84971/79065	4	ENSG00000088986,ENSG00000100330,ENSG00000130734,ENSG00000198925	DYNLL1,MTMR3,ATG4D,ATG9A
R-HSA-1169091	Activation of NF-kappaB in B cells	4/247	64/7349	0.167510342703634	0.6161005107569	0.554773270077269	4792/7316/5970/8517	4	ENSG00000100906,ENSG00000150991,ENSG00000173039,ENSG00000269335	NFKBIA,UBC,RELA,IKBKG
R-HSA-198753	ERK/MAPK targets	2/247	22/7349	0.167826662428403	0.6161005107569	0.554773270077269	5598/5600	2	ENSG00000166484,ENSG00000185386	MAPK7,MAPK11
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	2/247	22/7349	0.167826662428403	0.6161005107569	0.554773270077269	7316/8517	2	ENSG00000150991,ENSG00000269335	UBC,IKBKG
R-HSA-1236975	Antigen processing-Cross presentation	5/247	88/7349	0.173602373246345	0.631761680031266	0.568875511415942	4688/23480/1515/7316/8517	5	ENSG00000116701,ENSG00000132432,ENSG00000136943,ENSG00000150991,ENSG00000269335	NCF2,SEC61G,CTSV,UBC,IKBKG
R-HSA-4420097	VEGFA-VEGFR2 Pathway	5/247	88/7349	0.173602373246345	0.631761680031266	0.568875511415942	3315/4688/5747/8877/5600	5	ENSG00000106211,ENSG00000116701,ENSG00000169398,ENSG00000176170,ENSG00000185386	HSPB1,NCF2,PTK2,SPHK1,MAPK11
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	3/247	43/7349	0.174720711094659	0.633078940200127	0.570061650233656	8655/7277/1780	3	ENSG00000088986,ENSG00000127824,ENSG00000158560	DYNLL1,TUBA4A,DYNC1I1
R-HSA-442742	CREB phosphorylation through the activation of Ras	2/247	23/7349	0.179958078354792	0.64645884799554	0.582109709067228	5924/5894	2	ENSG00000113319,ENSG00000132155	RASGRF2,RAF1
R-HSA-76009	Platelet Aggregation (Plug Formation)	2/247	23/7349	0.179958078354792	0.64645884799554	0.582109709067228	10235/5747	2	ENSG00000068831,ENSG00000169398	RASGRP2,PTK2
R-HSA-199418	Negative regulation of the PI3K/AKT network	4/247	66/7349	0.180824727164172	0.646796139471846	0.582413426223784	5526/9173/3932/23396	4	ENSG00000068971,ENSG00000115602,ENSG00000182866,ENSG00000186111	PPP2R5B,IL1RL1,LCK,PIP5K1C
R-HSA-75153	Apoptotic execution phase	3/247	44/7349	0.183170116810403	0.652397394767265	0.58745712715005	118/329/5747	3	ENSG00000087274,ENSG00000110330,ENSG00000169398	ADD1,BIRC2,PTK2
R-HSA-68877	Mitotic Prometaphase	9/247	189/7349	0.185384539755172	0.657486693962197	0.59203983258119	27175/5526/8655/80152/7277/6396/1780/5116/9814	9	ENSG00000037042,ENSG00000068971,ENSG00000088986,ENSG00000102901,ENSG00000127824,ENSG00000157020,ENSG00000158560,ENSG00000160299,ENSG00000198089	TUBG2,PPP2R5B,DYNLL1,CENPT,TUBA4A,SEC13,DYNC1I1,PCNT,SFI1
R-HSA-380259	Loss of Nlp from mitotic centrosomes	4/247	67/7349	0.18761113935624	0.659792116139381	0.594115770805253	8655/7277/5116/9814	4	ENSG00000088986,ENSG00000127824,ENSG00000160299,ENSG00000198089	DYNLL1,TUBA4A,PCNT,SFI1
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	4/247	67/7349	0.18761113935624	0.659792116139381	0.594115770805253	8655/7277/5116/9814	4	ENSG00000088986,ENSG00000127824,ENSG00000160299,ENSG00000198089	DYNLL1,TUBA4A,PCNT,SFI1
R-HSA-8848021	Signaling by PTK6	3/247	45/7349	0.191726210697142	0.662080005691063	0.596175921618312	1027/7316/9021	3	ENSG00000111276,ENSG00000150991,ENSG00000184557	CDKN1B,UBC,SOCS3
R-HSA-9006927	Signaling by Non-Receptor Tyrosine Kinases	3/247	45/7349	0.191726210697142	0.662080005691063	0.596175921618312	1027/7316/9021	3	ENSG00000111276,ENSG00000150991,ENSG00000184557	CDKN1B,UBC,SOCS3
R-HSA-380994	ATF4 activates genes	2/247	24/7349	0.192216775845792	0.662080005691063	0.596175921618312	467/1649	2	ENSG00000162772,ENSG00000175197	ATF3,DDIT3
R-HSA-3928663	EPHA-mediated growth cone collapse	2/247	24/7349	0.192216775845792	0.662080005691063	0.596175921618312	25791/4637	2	ENSG00000066248,ENSG00000092841	NGEF,MYL6
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	2/247	24/7349	0.192216775845792	0.662080005691063	0.596175921618312	8717/1613	2	ENSG00000102871,ENSG00000167657	TRADD,DAPK3
R-HSA-5683057	MAPK family signaling cascades	10/247	217/7349	0.194336157171664	0.666050012443764	0.599750750059404	5526/9462/3315/5924/5894/11221/7316/1437/5747/3725	10	ENSG00000068971,ENSG00000075391,ENSG00000106211,ENSG00000113319,ENSG00000132155,ENSG00000143507,ENSG00000150991,ENSG00000164400,ENSG00000169398,ENSG00000177606	PPP2R5B,RASAL2,HSPB1,RASGRF2,RAF1,DUSP10,UBC,CSF2,PTK2,JUN
R-HSA-8856688	Golgi-to-ER retrograde transport	6/247	116/7349	0.194960875804925	0.666050012443764	0.599750750059404	381/8655/11316/7277/375/1780	6	ENSG00000004059,ENSG00000088986,ENSG00000105669,ENSG00000127824,ENSG00000143761,ENSG00000158560	ARF5,DYNLL1,COPE,TUBA4A,ARF1,DYNC1I1
R-HSA-162909	Host Interactions of HIV factors	6/247	117/7349	0.200175415863776	0.681084646658456	0.613288822244173	8907/375/7316/55690/3932/161	6	ENSG00000072958,ENSG00000143761,ENSG00000150991,ENSG00000175115,ENSG00000182866,ENSG00000183020	AP1M1,ARF1,UBC,PACS1,LCK,AP2A2
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	2/247	25/7349	0.204580615452089	0.681087295356893	0.613291207288607	56938/25819	2	ENSG00000029153,ENSG00000151014	ARNTL2,CCRN4L
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	2/247	25/7349	0.204580615452089	0.681087295356893	0.613291207288607	5598/5600	2	ENSG00000166484,ENSG00000185386	MAPK7,MAPK11
R-HSA-5673000	RAF activation	2/247	25/7349	0.204580615452089	0.681087295356893	0.613291207288607	5526/5894	2	ENSG00000068971,ENSG00000132155	PPP2R5B,RAF1
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	6/247	118/7349	0.205441220370429	0.681087295356893	0.613291207288607	5526/8655/80152/7277/6396/1780	6	ENSG00000068971,ENSG00000088986,ENSG00000102901,ENSG00000127824,ENSG00000157020,ENSG00000158560	PPP2R5B,DYNLL1,CENPT,TUBA4A,SEC13,DYNC1I1
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	4/247	70/7349	0.208441170610027	0.681087295356893	0.613291207288607	4650/5747/1072/10552	4	ENSG00000099331,ENSG00000169398,ENSG00000172757,ENSG00000241685	MYO9B,PTK2,CFL1,ARPC1A
R-HSA-427413	NoRC negatively regulates rRNA expression	4/247	70/7349	0.208441170610027	0.681087295356893	0.613291207288607	30834/23309/3021/8349	4	ENSG00000066379,ENSG00000127511,ENSG00000132475,ENSG00000184678	ZNRD1,SIN3B,H3F3B,HIST2H2BE
R-HSA-8854518	AURKA Activation by TPX2	4/247	70/7349	0.208441170610027	0.681087295356893	0.613291207288607	8655/7277/5116/9814	4	ENSG00000088986,ENSG00000127824,ENSG00000160299,ENSG00000198089	DYNLL1,TUBA4A,PCNT,SFI1
R-HSA-141424	Amplification of signal from the kinetochores	5/247	94/7349	0.208605124167575	0.681087295356893	0.613291207288607	5526/8655/80152/6396/1780	5	ENSG00000068971,ENSG00000088986,ENSG00000102901,ENSG00000157020,ENSG00000158560	PPP2R5B,DYNLL1,CENPT,SEC13,DYNC1I1
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	5/247	94/7349	0.208605124167575	0.681087295356893	0.613291207288607	5526/8655/80152/6396/1780	5	ENSG00000068971,ENSG00000088986,ENSG00000102901,ENSG00000157020,ENSG00000158560	PPP2R5B,DYNLL1,CENPT,SEC13,DYNC1I1
R-HSA-1912422	Pre-NOTCH Expression and Processing	3/247	47/7349	0.209127162373622	0.681087295356893	0.613291207288607	3955/5045/3725	3	ENSG00000106003,ENSG00000140564,ENSG00000177606	LFNG,FURIN,JUN
R-HSA-6809371	Formation of the cornified envelope	3/247	47/7349	0.209127162373622	0.681087295356893	0.613291207288607	11202/3855/5045	3	ENSG00000129455,ENSG00000135480,ENSG00000140564	KLK8,KRT7,FURIN
R-HSA-6785807	Interleukin-4 and 13 signaling	4/247	71/7349	0.215528584847655	0.696296641729083	0.62698660061375	3911/301/5292/9021	4	ENSG00000130702,ENSG00000135046,ENSG00000137193,ENSG00000184557	LAMA5,ANXA1,PIM1,SOCS3
R-HSA-2871796	FCERI mediated MAPK activation	2/247	26/7349	0.217028791052423	0.696296641729083	0.62698660061375	4214/3725	2	ENSG00000095015,ENSG00000177606	MAP3K1,JUN
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	2/247	26/7349	0.217028791052423	0.696296641729083	0.62698660061375	2782/2771	2	ENSG00000078369,ENSG00000114353	GNB1,GNAI2
R-HSA-2980736	Peptide hormone metabolism	3/247	48/7349	0.21795665487816	0.696296641729083	0.62698660061375	1509/3624/93659	3	ENSG00000117984,ENSG00000122641,ENSG00000189052,ENSG00000213030	CTSD,INHBA,CGB5,CGB8
R-HSA-6805567	Keratinization	3/247	48/7349	0.21795665487816	0.696296641729083	0.62698660061375	11202/3855/5045	3	ENSG00000129455,ENSG00000135480,ENSG00000140564	KLK8,KRT7,FURIN
R-HSA-9020702	Interleukin-1 signaling	5/247	97/7349	0.22691424417409	0.704847130960344	0.634685965877641	4791/4792/7316/5970/8517	5	ENSG00000077150,ENSG00000100906,ENSG00000150991,ENSG00000173039,ENSG00000269335	NFKB2,NFKBIA,UBC,RELA,IKBKG
R-HSA-162588	Budding and maturation of HIV virion	2/247	27/7349	0.229541765840779	0.704847130960344	0.634685965877641	7316/51271	2	ENSG00000150991,ENSG00000165006	UBC,UBAP1
R-HSA-381042	PERK regulates gene expression	2/247	27/7349	0.229541765840779	0.704847130960344	0.634685965877641	467/1649	2	ENSG00000162772,ENSG00000175197	ATF3,DDIT3
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	2/247	27/7349	0.229541765840779	0.704847130960344	0.634685965877641	2782/1437	2	ENSG00000078369,ENSG00000164400	GNB1,CSF2
R-HSA-418597	G alpha (z) signalling events	2/247	27/7349	0.229541765840779	0.704847130960344	0.634685965877641	2782/2771	2	ENSG00000078369,ENSG00000114353	GNB1,GNAI2
R-HSA-438064	Post NMDA receptor activation events	2/247	27/7349	0.229541765840779	0.704847130960344	0.634685965877641	5924/5894	2	ENSG00000113319,ENSG00000132155	RASGRF2,RAF1
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	2/247	27/7349	0.229541765840779	0.704847130960344	0.634685965877641	5526/1855	2	ENSG00000068971,ENSG00000107404	PPP2R5B,DVL1
R-HSA-73728	RNA Polymerase I Promoter Opening	2/247	27/7349	0.229541765840779	0.704847130960344	0.634685965877641	3021/8349	2	ENSG00000132475,ENSG00000184678	H3F3B,HIST2H2BE
R-HSA-8964043	Plasma lipoprotein clearance	2/247	27/7349	0.229541765840779	0.704847130960344	0.634685965877641	8029/161	2	ENSG00000107611,ENSG00000183020	CUBN,AP2A2
R-HSA-8979227	Triglyceride metabolism	2/247	27/7349	0.229541765840779	0.704847130960344	0.634685965877641	10226/5499	2	ENSG00000105355,ENSG00000172531	PLIN3,PPP1CA
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	4/247	73/7349	0.229896376047997	0.704847130960344	0.634685965877641	30834/23309/3021/8349	4	ENSG00000066379,ENSG00000127511,ENSG00000132475,ENSG00000184678	ZNRD1,SIN3B,H3F3B,HIST2H2BE
R-HSA-3214841	PKMTs methylate histone lysines	3/247	50/7349	0.235836225244743	0.720419417992152	0.648708172398139	4791/84787/5970	3	ENSG00000077150,ENSG00000133247,ENSG00000173039	NFKB2,SUV420H2,RELA
R-HSA-1483255	PI Metabolism	4/247	74/7349	0.237169072227775	0.721856412562357	0.65000212713909	8897/375/55361/23396	4	ENSG00000100330,ENSG00000143761,ENSG00000155252,ENSG00000186111	MTMR3,ARF1,PI4K2A,PIP5K1C
R-HSA-442755	Activation of NMDA receptor and postsynaptic events	2/247	28/7349	0.242101211082644	0.726303633247931	0.654006667176656	5924/5894	2	ENSG00000113319,ENSG00000132155	RASGRF2,RAF1
R-HSA-5334118	DNA methylation	2/247	28/7349	0.242101211082644	0.726303633247931	0.654006667176656	3021/8349	2	ENSG00000132475,ENSG00000184678	H3F3B,HIST2H2BE
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	2/247	28/7349	0.242101211082644	0.726303633247931	0.654006667176656	3021/8349	2	ENSG00000132475,ENSG00000184678	H3F3B,HIST2H2BE
R-HSA-8853659	RET signaling	2/247	28/7349	0.242101211082644	0.726303633247931	0.654006667176656	5598/9260	2	ENSG00000166484,ENSG00000196923	MAPK7,PDLIM7
R-HSA-5673001	RAF/MAP kinase cascade	8/247	177/7349	0.244698504857961	0.731201821160399	0.658417284727216	5526/9462/5924/5894/11221/7316/1437/5747	8	ENSG00000068971,ENSG00000075391,ENSG00000113319,ENSG00000132155,ENSG00000143507,ENSG00000150991,ENSG00000164400,ENSG00000169398	PPP2R5B,RASAL2,RASGRF2,RAF1,DUSP10,UBC,CSF2,PTK2
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	3/247	52/7349	0.253961644814184	0.731201821160399	0.658417284727216	3021/7090/8349	3	ENSG00000132475,ENSG00000140332,ENSG00000184678	H3F3B,TLE3,HIST2H2BE
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	3/247	52/7349	0.253961644814184	0.731201821160399	0.658417284727216	8818/29926/30815	3	ENSG00000136908,ENSG00000144591,ENSG00000160408	DPM2,GMPPA,ST6GALNAC6
R-HSA-109581	Apoptosis	7/247	153/7349	0.255239696507262	0.731201821160399	0.658417284727216	118/8655/8717/329/7316/1613/5747	7	ENSG00000087274,ENSG00000088986,ENSG00000102871,ENSG00000110330,ENSG00000150991,ENSG00000167657,ENSG00000169398	ADD1,DYNLL1,TRADD,BIRC2,UBC,DAPK3,PTK2
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	3/247	53/7349	0.263099028079368	0.731201821160399	0.658417284727216	9025/7316/8349	3	ENSG00000112130,ENSG00000150991,ENSG00000184678	RNF8,UBC,HIST2H2BE
R-HSA-397795	G-protein beta:gamma signalling	2/247	30/7349	0.267291889370521	0.731201821160399	0.658417284727216	2782/1437	2	ENSG00000078369,ENSG00000164400	GNB1,CSF2
R-HSA-5663084	Diseases of carbohydrate metabolism	2/247	30/7349	0.267291889370521	0.731201821160399	0.658417284727216	3423/7316	2	ENSG00000010404,ENSG00000150991	IDS,UBC
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	2/247	30/7349	0.267291889370521	0.731201821160399	0.658417284727216	997/7316	2	ENSG00000099804,ENSG00000150991	CDC34,UBC
R-HSA-5684996	MAPK1/MAPK3 signaling	8/247	182/7349	0.268485523601446	0.731201821160399	0.658417284727216	5526/9462/5924/5894/11221/7316/1437/5747	8	ENSG00000068971,ENSG00000075391,ENSG00000113319,ENSG00000132155,ENSG00000143507,ENSG00000150991,ENSG00000164400,ENSG00000169398	PPP2R5B,RASAL2,RASGRF2,RAF1,DUSP10,UBC,CSF2,PTK2
R-HSA-5357801	Programmed Cell Death	7/247	156/7349	0.270838838616779	0.731201821160399	0.658417284727216	118/8655/8717/329/7316/1613/5747	7	ENSG00000087274,ENSG00000088986,ENSG00000102871,ENSG00000110330,ENSG00000150991,ENSG00000167657,ENSG00000169398	ADD1,DYNLL1,TRADD,BIRC2,UBC,DAPK3,PTK2
R-HSA-418346	Platelet homeostasis	3/247	54/7349	0.272277175169534	0.731201821160399	0.658417284727216	5526/2782/5152	3	ENSG00000068971,ENSG00000078369,ENSG00000160191	PPP2R5B,GNB1,PDE9A
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	3/247	54/7349	0.272277175169534	0.731201821160399	0.658417284727216	3315/7316/3303	3	ENSG00000106211,ENSG00000150991,ENSG00000204389	HSPB1,UBC,HSPA1A
R-HSA-5693606	DNA Double Strand Break Response	3/247	54/7349	0.272277175169534	0.731201821160399	0.658417284727216	9025/7316/8349	3	ENSG00000112130,ENSG00000150991,ENSG00000184678	RNF8,UBC,HIST2H2BE
R-HSA-73777	RNA Polymerase I Chain Elongation	3/247	54/7349	0.272277175169534	0.731201821160399	0.658417284727216	30834/3021/8349	3	ENSG00000066379,ENSG00000132475,ENSG00000184678	ZNRD1,H3F3B,HIST2H2BE
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	4/247	79/7349	0.274268883674233	0.731201821160399	0.658417284727216	4792/7316/5970/8517	4	ENSG00000100906,ENSG00000150991,ENSG00000173039,ENSG00000269335	NFKBIA,UBC,RELA,IKBKG
R-HSA-195253	Degradation of beta-catenin by the destruction complex	4/247	79/7349	0.274268883674233	0.731201821160399	0.658417284727216	5526/7090/7316/1487	4	ENSG00000068971,ENSG00000140332,ENSG00000150991,ENSG00000159692	PPP2R5B,TLE3,UBC,CTBP1
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	4/247	79/7349	0.274268883674233	0.731201821160399	0.658417284727216	3021/3725/8349/63925	4	ENSG00000132475,ENSG00000177606,ENSG00000184678,ENSG00000198026	H3F3B,JUN,HIST2H2BE,ZNF335
R-HSA-5619507	Activation of HOX genes during differentiation	4/247	79/7349	0.274268883674233	0.731201821160399	0.658417284727216	3021/3725/8349/63925	4	ENSG00000132475,ENSG00000177606,ENSG00000184678,ENSG00000198026	H3F3B,JUN,HIST2H2BE,ZNF335
R-HSA-5688426	Deubiquitination	10/247	237/7349	0.274681020819741	0.731201821160399	0.658417284727216	55593/79594/4792/23770/329/7316/10474/8349/9146/8517	10	ENSG00000068308,ENSG00000090432,ENSG00000100906,ENSG00000105701,ENSG00000110330,ENSG00000150991,ENSG00000171148,ENSG00000184678,ENSG00000185359,ENSG00000269335	OTUD5,MUL1,NFKBIA,FKBP8,BIRC2,UBC,TADA3,HIST2H2BE,HGS,IKBKG
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	2/247	31/7349	0.279891990655737	0.731201821160399	0.658417284727216	5747/10552	2	ENSG00000169398,ENSG00000241685	PTK2,ARPC1A
R-HSA-432722	Golgi Associated Vesicle Biogenesis	3/247	55/7349	0.281489534048559	0.731201821160399	0.658417284727216	8907/8301/375	3	ENSG00000072958,ENSG00000073921,ENSG00000143761	AP1M1,PICALM,ARF1
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	3/247	55/7349	0.281489534048559	0.731201821160399	0.658417284727216	30834/3021/8349	3	ENSG00000066379,ENSG00000132475,ENSG00000184678	ZNRD1,H3F3B,HIST2H2BE
R-HSA-8936459	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	3/247	55/7349	0.281489534048559	0.731201821160399	0.658417284727216	23309/3021/8349	3	ENSG00000127511,ENSG00000132475,ENSG00000184678	SIN3B,H3F3B,HIST2H2BE
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	4/247	80/7349	0.281810047680985	0.731201821160399	0.658417284727216	4791/5971/329/7316	4	ENSG00000077150,ENSG00000104856,ENSG00000110330,ENSG00000150991	NFKB2,RELB,BIRC2,UBC
R-HSA-416476	G alpha (q) signalling events	5/247	106/7349	0.284314270511738	0.731201821160399	0.658417284727216	2769/10235/2782/301/5598	5	ENSG00000060558,ENSG00000068831,ENSG00000078369,ENSG00000135046,ENSG00000166484	GNA15,RASGRP2,GNB1,ANXA1,MAPK7
R-HSA-1059683	Interleukin-6 signaling	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	9021	1	ENSG00000184557	SOCS3
R-HSA-1170546	Prolactin receptor signaling	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	6777	1	ENSG00000173757	STAT5B
R-HSA-1236977	Endosomal/Vacuolar pathway	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	1515	1	ENSG00000136943	CTSV
R-HSA-1296065	Inwardly rectifying K+ channels	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	2782	1	ENSG00000078369	GNB1
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	7316	1	ENSG00000150991	UBC
R-HSA-1483115	Hydrolysis of LPC	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	56261	1	ENSG00000125772	GPCPD1
R-HSA-1679131	Trafficking and processing of endosomal TLR	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	1515	1	ENSG00000136943	CTSV
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	1646	1	ENSG00000151632	AKR1C2
R-HSA-2022870	Chondroitin sulfate biosynthesis	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	55454	1	ENSG00000169826	CSGALNACT2
R-HSA-209543	p75NTR recruits signalling complexes	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	7316	1	ENSG00000150991	UBC
R-HSA-210990	PECAM1 interactions	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	3932	1	ENSG00000182866	LCK
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	6812	1	ENSG00000136854	STXBP1
R-HSA-3371378	Regulation by c-FLIP	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	8717	1	ENSG00000102871	TRADD
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	6385	1	ENSG00000124145	SDC4
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	6385	1	ENSG00000124145	SDC4
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	1649	1	ENSG00000175197	DDIT3
R-HSA-381753	Olfactory Signaling Pathway	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	2782	1	ENSG00000078369	GNB1
R-HSA-390247	Beta-oxidation of very long chain fatty acids	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	122970	1	ENSG00000177465	ACOT4
R-HSA-399997	Acetylcholine regulates insulin secretion	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	2769	1	ENSG00000060558	GNA15
R-HSA-418457	cGMP effects	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	5152	1	ENSG00000160191	PDE9A
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	6385	1	ENSG00000124145	SDC4
R-HSA-5218900	CASP8 activity is inhibited	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	8717	1	ENSG00000102871	TRADD
R-HSA-5689877	Josephin domain DUBs	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	7316	1	ENSG00000150991	UBC
R-HSA-69416	Dimerization of procaspase-8	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	8717	1	ENSG00000102871	TRADD
R-HSA-75205	Dissolution of Fibrin Clot	1/247	10/7349	0.28971664598156	0.731201821160399	0.658417284727216	5328	1	ENSG00000122861	PLAU
R-HSA-427359	SIRT1 negatively regulates rRNA expression	2/247	32/7349	0.292476194026879	0.731201821160399	0.658417284727216	3021/8349	2	ENSG00000132475,ENSG00000184678	H3F3B,HIST2H2BE
R-HSA-5578775	Ion homeostasis	2/247	32/7349	0.292476194026879	0.731201821160399	0.658417284727216	7220/1193	2	ENSG00000144935,ENSG00000155962	TRPC1,CLIC2
R-HSA-1257604	PIP3 activates AKT signaling	9/247	214/7349	0.292756266058029	0.731201821160399	0.658417284727216	6591/5526/1027/9173/7316/3725/84232/3932/23396	9	ENSG00000019549,ENSG00000068971,ENSG00000111276,ENSG00000115602,ENSG00000150991,ENSG00000177606,ENSG00000179632,ENSG00000182866,ENSG00000186111	SNAI2,PPP2R5B,CDKN1B,IL1RL1,UBC,JUN,MAF1,LCK,PIP5K1C
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	4/247	82/7349	0.296984491785064	0.731201821160399	0.658417284727216	51343/1027/7316/55957	4	ENSG00000105325,ENSG00000111276,ENSG00000150991,ENSG00000267796	FZR1,CDKN1B,UBC,LIN37
R-HSA-9018519	Estrogen-dependent gene expression	5/247	108/7349	0.297452615520758	0.731201821160399	0.658417284727216	1509/3021/7090/3725/8349	5	ENSG00000117984,ENSG00000132475,ENSG00000140332,ENSG00000177606,ENSG00000184678	CTSD,H3F3B,TLE3,JUN,HIST2H2BE
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	5/247	108/7349	0.297452615520758	0.731201821160399	0.658417284727216	4792/7220/7316/5970/8517	5	ENSG00000100906,ENSG00000144935,ENSG00000150991,ENSG00000173039,ENSG00000269335	NFKBIA,TRPC1,UBC,RELA,IKBKG
R-HSA-111885	Opioid Signalling	3/247	57/7349	0.299991552112281	0.731201821160399	0.658417284727216	2782/2771/5499	3	ENSG00000078369,ENSG00000114353,ENSG00000172531	GNB1,GNAI2,PPP1CA
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	3/247	57/7349	0.299991552112281	0.731201821160399	0.658417284727216	4791/5971/7316	3	ENSG00000077150,ENSG00000104856,ENSG00000150991	NFKB2,RELB,UBC
R-HSA-202733	Cell surface interactions at the vascular wall	4/247	83/7349	0.304610706952247	0.731201821160399	0.658417284727216	6385/3678/3932/3897	4	ENSG00000124145,ENSG00000161638,ENSG00000182866,ENSG00000198910	SDC4,ITGA5,LCK,L1CAM
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	2/247	33/7349	0.305031381723682	0.731201821160399	0.658417284727216	3423/6385	2	ENSG00000010404,ENSG00000124145	IDS,SDC4
R-HSA-2559585	Oncogene Induced Senescence	2/247	33/7349	0.305031381723682	0.731201821160399	0.658417284727216	2113/7316	2	ENSG00000134954,ENSG00000150991	ETS1,UBC
R-HSA-8943724	Regulation of PTEN gene transcription	3/247	58/7349	0.309268988640669	0.731201821160399	0.658417284727216	6591/3725/84232	3	ENSG00000019549,ENSG00000177606,ENSG00000179632	SNAI2,JUN,MAF1
R-HSA-69618	Mitotic Spindle Checkpoint	5/247	110/7349	0.31068985884295	0.731201821160399	0.658417284727216	5526/8655/80152/6396/1780	5	ENSG00000068971,ENSG00000088986,ENSG00000102901,ENSG00000157020,ENSG00000158560	PPP2R5B,DYNLL1,CENPT,SEC13,DYNC1I1
R-HSA-1630316	Glycosaminoglycan metabolism	4/247	84/7349	0.312258294099382	0.731201821160399	0.658417284727216	3423/6385/55454/3037	4	ENSG00000010404,ENSG00000124145,ENSG00000169826,ENSG00000170961	IDS,SDC4,CSGALNACT2,HAS2
R-HSA-166520	Signaling by NTRKs	4/247	84/7349	0.312258294099382	0.731201821160399	0.658417284727216	5045/5598/161/5600	4	ENSG00000140564,ENSG00000166484,ENSG00000183020,ENSG00000185386	FURIN,MAPK7,AP2A2,MAPK11
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	4/247	84/7349	0.312258294099382	0.731201821160399	0.658417284727216	381/11316/7277/375	4	ENSG00000004059,ENSG00000105669,ENSG00000127824,ENSG00000143761	ARF5,COPE,TUBA4A,ARF1
R-HSA-177504	Retrograde neurotrophin signalling	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	161	1	ENSG00000183020	AP2A2
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	6812	1	ENSG00000136854	STXBP1
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	7277	1	ENSG00000127824	TUBA4A
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	1646	1	ENSG00000151632	AKR1C2
R-HSA-2206281	Mucopolysaccharidoses	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	3423	1	ENSG00000010404	IDS
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	161	1	ENSG00000183020	AP2A2
R-HSA-418217	G beta:gamma signalling through PLC beta	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	2782	1	ENSG00000078369	GNB1
R-HSA-420092	Glucagon-type ligand receptors	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	2782	1	ENSG00000078369	GNB1
R-HSA-500657	Presynaptic function of Kainate receptors	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	2782	1	ENSG00000078369	GNB1
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	161	1	ENSG00000183020	AP2A2
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	329	1	ENSG00000110330	BIRC2
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	10848	1	ENSG00000104881	PPP1R13L
R-HSA-888590	GABA synthesis, release, reuptake and degradation	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	6812	1	ENSG00000136854	STXBP1
R-HSA-8963889	Assembly of active LPL and LIPC lipase complexes	1/247	11/7349	0.313621808598068	0.731201821160399	0.658417284727216	5045	1	ENSG00000140564	FURIN
R-HSA-9007101	Rab regulation of trafficking	5/247	111/7349	0.317339884712367	0.734789194070686	0.661647567068617	89781/11021/116442/51112/2664	5	ENSG00000100099,ENSG00000111737,ENSG00000155961,ENSG00000171853,ENSG00000203879	HPS4,RAB35,RAB39B,TRAPPC12,GDI1
R-HSA-936440	Negative regulators of DDX58/IFIH1 signaling	2/247	34/7349	0.317545328735092	0.734789194070686	0.661647567068617	55593/7316	2	ENSG00000068308,ENSG00000150991	OTUD5,UBC
R-HSA-157118	Signaling by NOTCH	5/247	112/7349	0.324007856565297	0.734789194070686	0.661647567068617	3955/7090/5045/7316/3725	5	ENSG00000106003,ENSG00000140332,ENSG00000140564,ENSG00000150991,ENSG00000177606	LFNG,TLE3,FURIN,UBC,JUN
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	4/247	86/7349	0.327604047211211	0.734789194070686	0.661647567068617	3315/7316/5600/3303	4	ENSG00000106211,ENSG00000150991,ENSG00000185386,ENSG00000204389	HSPB1,UBC,MAPK11,HSPA1A
R-HSA-446728	Cell junction organization	3/247	60/7349	0.327847515350842	0.734789194070686	0.661647567068617	3918/5817/3914	3	ENSG00000058085,ENSG00000073008,ENSG00000196878	LAMC2,PVR,LAMB3
R-HSA-6798695	Neutrophil degranulation	14/247	361/7349	0.32849075027724	0.734789194070686	0.661647567068617	64386/7077/1265/8907/8655/201294/5768/1509/5328/6727/963/161/9725/3303	14	ENSG00000008516,ENSG00000035862,ENSG00000064666,ENSG00000072958,ENSG00000088986,ENSG00000092929,ENSG00000116260,ENSG00000117984,ENSG00000122861,ENSG00000140319,ENSG00000143119,ENSG00000183020,ENSG00000196187,ENSG00000204389	MMP25,TIMP2,CNN2,AP1M1,DYNLL1,UNC13D,QSOX1,CTSD,PLAU,SRP14,CD53,AP2A2,TMEM63A,HSPA1A
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	2/247	35/7349	0.330006658019472	0.734789194070686	0.661647567068617	1294/5034	2	ENSG00000114270,ENSG00000185624	COL7A1,P4HB
R-HSA-375165	NCAM signaling for neurite out-growth	2/247	35/7349	0.330006658019472	0.734789194070686	0.661647567068617	784/5747	2	ENSG00000167535,ENSG00000169398	CACNB3,PTK2
R-HSA-8939211	ESR-mediated signaling	5/247	113/7349	0.330691559998348	0.734789194070686	0.661647567068617	1509/3021/7090/3725/8349	5	ENSG00000117984,ENSG00000132475,ENSG00000140332,ENSG00000177606,ENSG00000184678	CTSD,H3F3B,TLE3,JUN,HIST2H2BE
R-HSA-1614558	Degradation of cysteine and homocysteine	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	58472	1	ENSG00000137767	SQRDL
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	6812	1	ENSG00000136854	STXBP1
R-HSA-190872	Transport of connexons to the plasma membrane	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	7277	1	ENSG00000127824	TUBA4A
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	118	1	ENSG00000087274	ADD1
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	1649	1	ENSG00000175197	DDIT3
R-HSA-5210891	Uptake and function of anthrax toxins	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	5045	1	ENSG00000140564	FURIN
R-HSA-5357786	TNFR1-induced proapoptotic signaling	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	8717	1	ENSG00000102871	TRADD
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	3486	1	ENSG00000146674	IGFBP3
R-HSA-8866427	VLDLR internalisation and degradation	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	161	1	ENSG00000183020	AP2A2
R-HSA-9013973	TICAM1-dependent activation of IRF3/IRF7	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	7316	1	ENSG00000150991	UBC
R-HSA-9018677	Biosynthesis of DHA-derived SPMs	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	2879	1	ENSG00000167468	GPX4
R-HSA-912694	Regulation of IFNA signaling	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	9021	1	ENSG00000184557	SOCS3
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	8517	1	ENSG00000269335	IKBKG
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	1/247	12/7349	0.336725571650164	0.734789194070686	0.661647567068617	7316	1	ENSG00000150991	UBC
R-HSA-500792	GPCR ligand binding	6/247	141/7349	0.337036086772887	0.734789194070686	0.661647567068617	23596/2782/5744/301/90226/136	6	ENSG00000054277,ENSG00000078369,ENSG00000087494,ENSG00000135046,ENSG00000145040,ENSG00000170425	OPN3,GNB1,PTHLH,ANXA1,UCN2,ADORA2B
R-HSA-383280	Nuclear Receptor transcription pathway	2/247	36/7349	0.342404797706835	0.734789194070686	0.661647567068617	5467/29959	2	ENSG00000112033,ENSG00000115216	PPARD,NRBP1
R-HSA-15869	Metabolism of nucleotides	4/247	88/7349	0.34299526857636	0.734789194070686	0.661647567068617	1890/7378/955/79873	4	ENSG00000025708,ENSG00000183696,ENSG00000197586,ENSG00000275074	TYMP,UPP1,ENTPD6,NUDT18
R-HSA-1433557	Signaling by SCF-KIT	2/247	37/7349	0.354729940201298	0.734789194070686	0.661647567068617	6777/3932	2	ENSG00000173757,ENSG00000182866	STAT5B,LCK
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	2/247	37/7349	0.354729940201298	0.734789194070686	0.661647567068617	5817/100507436	2	ENSG00000073008,ENSG00000204520	PVR,MICA
R-HSA-212300	PRC2 methylates histones and DNA	2/247	37/7349	0.354729940201298	0.734789194070686	0.661647567068617	3021/8349	2	ENSG00000132475,ENSG00000184678	H3F3B,HIST2H2BE
R-HSA-2299718	Condensation of Prophase Chromosomes	2/247	37/7349	0.354729940201298	0.734789194070686	0.661647567068617	3021/8349	2	ENSG00000132475,ENSG00000184678	H3F3B,HIST2H2BE
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	2/247	37/7349	0.354729940201298	0.734789194070686	0.661647567068617	6468/8877	2	ENSG00000107829,ENSG00000176170	FBXW4,SPHK1
R-HSA-5576891	Cardiac conduction	3/247	63/7349	0.355692314752651	0.734789194070686	0.661647567068617	7220/1193/784	3	ENSG00000144935,ENSG00000155962,ENSG00000167535	TRPC1,CLIC2,CACNB3
R-HSA-1181150	Signaling by NODAL	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	5045	1	ENSG00000140564	FURIN
R-HSA-1502540	Signaling by Activin	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	3624	1	ENSG00000122641	INHBA
R-HSA-171007	p38MAPK events	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	5600	1	ENSG00000185386	MAPK11
R-HSA-198323	AKT phosphorylates targets in the cytosol	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	1027	1	ENSG00000111276	CDKN1B
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	5467	1	ENSG00000112033	PPARD
R-HSA-202670	ERKs are inactivated	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	5598	1	ENSG00000166484	MAPK7
R-HSA-205043	NRIF signals cell death from the nucleus	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	7316	1	ENSG00000150991	UBC
R-HSA-3229121	Glycogen storage diseases	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	7316	1	ENSG00000150991	UBC
R-HSA-3296469	Defects in cobalamin (B12) metabolism	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	8029	1	ENSG00000107611	CUBN
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	5152	1	ENSG00000160191	PDE9A
R-HSA-435354	Zinc transporters	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	55630	1	ENSG00000147804	SLC39A4
R-HSA-442982	Ras activation upon Ca2+ influx through NMDA receptor	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	5924	1	ENSG00000113319	RASGRF2
R-HSA-5099900	WNT5A-dependent internalization of FZD4	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	161	1	ENSG00000183020	AP2A2
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	1027	1	ENSG00000111276	CDKN1B
R-HSA-877312	Regulation of IFNG signaling	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	9021	1	ENSG00000184557	SOCS3
R-HSA-8849932	Synaptic adhesion-like molecules	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	10211	1	ENSG00000137312	FLOT1
R-HSA-8983432	Interleukin-15 signaling	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	6777	1	ENSG00000173757	STAT5B
R-HSA-9018678	Biosynthesis of specialized proresolving mediators (SPMs)	1/247	13/7349	0.359054695788423	0.734789194070686	0.661647567068617	2879	1	ENSG00000167468	GPX4
R-HSA-9006931	Signaling by Nuclear Receptors	6/247	145/7349	0.361155311201976	0.737285354819644	0.663895257562555	5467/1509/3021/7090/3725/8349	6	ENSG00000112033,ENSG00000117984,ENSG00000132475,ENSG00000140332,ENSG00000177606,ENSG00000184678	PPARD,CTSD,H3F3B,TLE3,JUN,HIST2H2BE
R-HSA-877300	Interferon gamma signaling	3/247	64/7349	0.364947165837028	0.740910553903572	0.667159600823691	3664/80128/9021	3	ENSG00000117595,ENSG00000163462,ENSG00000184557	IRF6,TRIM46,SOCS3
R-HSA-5619102	SLC transporter disorders	2/247	38/7349	0.366973003105161	0.740910553903572	0.667159600823691	55630/10999	2	ENSG00000147804,ENSG00000167114	SLC39A4,SLC27A4
R-HSA-6783310	Fanconi Anemia Pathway	2/247	38/7349	0.366973003105161	0.740910553903572	0.667159600823691	2067/7316	2	ENSG00000012061,ENSG00000150991	ERCC1,UBC
R-HSA-8878171	Transcriptional regulation by RUNX1	7/247	174/7349	0.36851367274694	0.740910553903572	0.667159600823691	23309/3021/1515/7316/1437/9021/8349	7	ENSG00000127511,ENSG00000132475,ENSG00000136943,ENSG00000150991,ENSG00000164400,ENSG00000184557,ENSG00000184678	SIN3B,H3F3B,CTSV,UBC,CSF2,SOCS3,HIST2H2BE
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	6385	1	ENSG00000124145	SDC4
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	6812	1	ENSG00000136854	STXBP1
R-HSA-2142845	Hyaluronan metabolism	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	3037	1	ENSG00000170961	HAS2
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	7316	1	ENSG00000150991	UBC
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	7316	1	ENSG00000150991	UBC
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	7316	1	ENSG00000150991	UBC
R-HSA-3322077	Glycogen synthesis	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	7316	1	ENSG00000150991	UBC
R-HSA-3371568	Attenuation phase	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	3303	1	ENSG00000204389	HSPA1A
R-HSA-432142	Platelet sensitization by LDL	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	5526	1	ENSG00000068971	PPP2R5B
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	5526	1	ENSG00000068971	PPP2R5B
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	5526	1	ENSG00000068971	PPP2R5B
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	5526	1	ENSG00000068971	PPP2R5B
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	5526	1	ENSG00000068971	PPP2R5B
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	5526	1	ENSG00000068971	PPP2R5B
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	5526	1	ENSG00000068971	PPP2R5B
R-HSA-6803157	Antimicrobial peptides	1/247	14/7349	0.380635051587259	0.740910553903572	0.667159600823691	92747	1	ENSG00000125999	BPIFB1
R-HSA-186797	Signaling by PDGF	2/247	40/7349	0.391179964236317	0.744556821666952	0.670442915567551	5045/6777	2	ENSG00000140564,ENSG00000173757	FURIN,STAT5B
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	2/247	40/7349	0.391179964236317	0.744556821666952	0.670442915567551	3021/8349	2	ENSG00000132475,ENSG00000184678	H3F3B,HIST2H2BE
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	3/247	67/7349	0.392565046447531	0.744556821666952	0.670442915567551	8818/29926/30815	3	ENSG00000136908,ENSG00000144591,ENSG00000160408	DPM2,GMPPA,ST6GALNAC6
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	4/247	95/7349	0.396864102307065	0.744556821666952	0.670442915567551	8655/7277/5116/9814	4	ENSG00000088986,ENSG00000127824,ENSG00000160299,ENSG00000198089	DYNLL1,TUBA4A,PCNT,SFI1
R-HSA-110312	Translesion synthesis by REV1	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	7316	1	ENSG00000150991	UBC
R-HSA-140534	Ligand-dependent caspase activation	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	8717	1	ENSG00000102871	TRADD
R-HSA-1433559	Regulation of KIT signaling	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	3932	1	ENSG00000182866	LCK
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	5467	1	ENSG00000112033	PPARD
R-HSA-419037	NCAM1 interactions	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	784	1	ENSG00000167535	CACNB3
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	5526	1	ENSG00000068971	PPP2R5B
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	5526	1	ENSG00000068971	PPP2R5B
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	5526	1	ENSG00000068971	PPP2R5B
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	5526	1	ENSG00000068971	PPP2R5B
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	5526	1	ENSG00000068971	PPP2R5B
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	5526	1	ENSG00000068971	PPP2R5B
R-HSA-5609975	Diseases associated with glycosylation precursor biosynthesis	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	8818	1	ENSG00000136908	DPM2
R-HSA-8854691	Interleukin-20 family signaling	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	6777	1	ENSG00000173757	STAT5B
R-HSA-9014325	TICAM1,TRAF6-dependent induction of TAK1 complex	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	7316	1	ENSG00000150991	UBC
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	1/247	15/7349	0.401491649032105	0.744556821666952	0.670442915567551	7316	1	ENSG00000150991	UBC
R-HSA-8852135	Protein ubiquitination	3/247	68/7349	0.401707498424641	0.744556821666952	0.670442915567551	997/7316/51255	3	ENSG00000099804,ENSG00000150991,ENSG00000168894	CDC34,UBC,RNF181
R-HSA-2467813	Separation of Sister Chromatids	7/247	180/7349	0.401843768638178	0.744556821666952	0.670442915567551	5526/8655/80152/7277/7316/6396/1780	7	ENSG00000068971,ENSG00000088986,ENSG00000102901,ENSG00000127824,ENSG00000150991,ENSG00000157020,ENSG00000158560	PPP2R5B,DYNLL1,CENPT,TUBA4A,UBC,SEC13,DYNC1I1
R-HSA-9006925	Intracellular signaling by second messengers	9/247	237/7349	0.402379283397039	0.744556821666952	0.670442915567551	6591/5526/1027/9173/7316/3725/84232/3932/23396	9	ENSG00000019549,ENSG00000068971,ENSG00000111276,ENSG00000115602,ENSG00000150991,ENSG00000177606,ENSG00000179632,ENSG00000182866,ENSG00000186111	SNAI2,PPP2R5B,CDKN1B,IL1RL1,UBC,JUN,MAF1,LCK,PIP5K1C
R-HSA-5696400	Dual Incision in GG-NER	2/247	41/7349	0.403128995989988	0.744556821666952	0.670442915567551	2067/7316	2	ENSG00000012061,ENSG00000150991	ERCC1,UBC
R-HSA-983169	Class I MHC mediated antigen processing & presentation	12/247	325/7349	0.411076914359184	0.744556821666952	0.670442915567551	997/51343/6468/4688/10489/23480/1515/7316/6396/80176/9021/8517	12	ENSG00000099804,ENSG00000105325,ENSG00000107829,ENSG00000116701,ENSG00000132128,ENSG00000132432,ENSG00000136943,ENSG00000150991,ENSG00000157020,ENSG00000171621,ENSG00000184557,ENSG00000269335	CDC34,FZR1,FBXW4,NCF2,LRRC41,SEC61G,CTSV,UBC,SEC13,SPSB1,SOCS3,IKBKG
R-HSA-69275	G2/M Transition	7/247	182/7349	0.412959029559876	0.744556821666952	0.670442915567551	27175/8655/7277/7316/5116/9814/55957	7	ENSG00000037042,ENSG00000088986,ENSG00000127824,ENSG00000150991,ENSG00000160299,ENSG00000198089,ENSG00000267796	TUBG2,DYNLL1,TUBA4A,UBC,PCNT,SFI1,LIN37
R-HSA-216083	Integrin cell surface interactions	2/247	42/7349	0.414966148638877	0.744556821666952	0.670442915567551	1294/3678	2	ENSG00000114270,ENSG00000161638	COL7A1,ITGA5
R-HSA-388841	Costimulation by the CD28 family	2/247	42/7349	0.414966148638877	0.744556821666952	0.670442915567551	5526/3932	2	ENSG00000068971,ENSG00000182866	PPP2R5B,LCK
R-HSA-162906	HIV Infection	8/247	211/7349	0.415289392561502	0.744556821666952	0.670442915567551	8907/5045/375/7316/51271/55690/3932/161	8	ENSG00000072958,ENSG00000140564,ENSG00000143761,ENSG00000150991,ENSG00000165006,ENSG00000175115,ENSG00000182866,ENSG00000183020	AP1M1,FURIN,ARF1,UBC,UBAP1,PACS1,LCK,AP2A2
R-HSA-1500620	Meiosis	3/247	70/7349	0.419872679772697	0.744556821666952	0.670442915567551	23345/3021/8349	3	ENSG00000131018,ENSG00000132475,ENSG00000184678	SYNE1,H3F3B,HIST2H2BE
R-HSA-187037	Signaling by NTRK1 (TRKA)	3/247	70/7349	0.419872679772697	0.744556821666952	0.670442915567551	5598/161/5600	3	ENSG00000166484,ENSG00000183020,ENSG00000185386	MAPK7,AP2A2,MAPK11
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	3/247	70/7349	0.419872679772697	0.744556821666952	0.670442915567551	30834/3021/8349	3	ENSG00000066379,ENSG00000132475,ENSG00000184678	ZNRD1,H3F3B,HIST2H2BE
R-HSA-1295596	Spry regulation of FGF signaling	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	7316	1	ENSG00000150991	UBC
R-HSA-1362300	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	55957	1	ENSG00000267796	LIN37
R-HSA-156711	Polo-like kinase mediated events	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	55957	1	ENSG00000267796	LIN37
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	55361	1	ENSG00000155252	PI4K2A
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	8029	1	ENSG00000107611	CUBN
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	6812	1	ENSG00000136854	STXBP1
R-HSA-3238698	WNT ligand biogenesis and trafficking	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	64840	1	ENSG00000102312	PORCN
R-HSA-4641263	Regulation of FZD by ubiquitination	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	7316	1	ENSG00000150991	UBC
R-HSA-5655862	Translesion synthesis by POLK	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	7316	1	ENSG00000150991	UBC
R-HSA-5656121	Translesion synthesis by POLI	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	7316	1	ENSG00000150991	UBC
R-HSA-74259	Purine catabolism	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	79873	1	ENSG00000275074	NUDT18
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	5598	1	ENSG00000166484	MAPK7
R-HSA-937072	TRAF6-mediated induction of TAK1 complex within TLR4 complex	1/247	16/7349	0.421648666033615	0.744556821666952	0.670442915567551	7316	1	ENSG00000150991	UBC
R-HSA-453274	Mitotic G2-G2/M phases	7/247	184/7349	0.424062356943036	0.747145840661771	0.672774221107751	27175/8655/7277/7316/5116/9814/55957	7	ENSG00000037042,ENSG00000088986,ENSG00000127824,ENSG00000150991,ENSG00000160299,ENSG00000198089,ENSG00000267796	TUBG2,DYNLL1,TUBA4A,UBC,PCNT,SFI1,LIN37
R-HSA-5696395	Formation of Incision Complex in GG-NER	2/247	43/7349	0.426685438275181	0.747145840661771	0.672774221107751	2067/7316	2	ENSG00000012061,ENSG00000150991	ERCC1,UBC
R-HSA-69231	Cyclin D associated events in G1	2/247	43/7349	0.426685438275181	0.747145840661771	0.672774221107751	1027/7316	2	ENSG00000111276,ENSG00000150991	CDKN1B,UBC
R-HSA-69236	G1 Phase	2/247	43/7349	0.426685438275181	0.747145840661771	0.672774221107751	1027/7316	2	ENSG00000111276,ENSG00000150991	CDKN1B,UBC
R-HSA-1221632	Meiotic synapsis	2/247	44/7349	0.43828140596398	0.748935844650522	0.674386046368325	23345/8349	2	ENSG00000131018,ENSG00000184678	SYNE1,HIST2H2BE
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	2/247	44/7349	0.43828140596398	0.748935844650522	0.674386046368325	7090/7316	2	ENSG00000140332,ENSG00000150991	TLE3,UBC
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	8818	1	ENSG00000136908	DPM2
R-HSA-167044	Signalling to RAS	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	5600	1	ENSG00000185386	MAPK11
R-HSA-196299	Beta-catenin phosphorylation cascade	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	5526	1	ENSG00000068971	PPP2R5B
R-HSA-2022928	HS-GAG biosynthesis	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	6385	1	ENSG00000124145	SDC4
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	2782	1	ENSG00000078369	GNB1
R-HSA-389977	Post-chaperonin tubulin folding pathway	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	7277	1	ENSG00000127824	TUBA4A
R-HSA-390522	Striated Muscle Contraction	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	7139	1	ENSG00000118194	TNNT2
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	5600	1	ENSG00000185386	MAPK11
R-HSA-5576892	Phase 0 - rapid depolarisation	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	784	1	ENSG00000167535	CACNB3
R-HSA-8948216	Collagen chain trimerization	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	1294	1	ENSG00000114270	COL7A1
R-HSA-8964038	LDL clearance	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	161	1	ENSG00000183020	AP2A2
R-HSA-912526	Interleukin receptor SHC signaling	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	1437	1	ENSG00000164400	CSF2
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	1/247	17/7349	0.441129476000845	0.748935844650522	0.674386046368325	7316	1	ENSG00000150991	UBC
R-HSA-3214847	HATs acetylate histones	4/247	101/7349	0.442488307826475	0.749722092410444	0.675094030265834	51147/55683/10474/8349	4	ENSG00000111653,ENSG00000114982,ENSG00000171148,ENSG00000184678	ING4,KANSL3,TADA3,HIST2H2BE
R-HSA-73854	RNA Polymerase I Promoter Clearance	3/247	73/7349	0.446765791638423	0.755440338588607	0.680243076689231	30834/3021/8349	3	ENSG00000066379,ENSG00000132475,ENSG00000184678	ZNRD1,H3F3B,HIST2H2BE
R-HSA-6802949	Signaling by RAS mutants	2/247	45/7349	0.449749089464763	0.75784200110266	0.682405675393957	9462/5894	2	ENSG00000075391,ENSG00000132155	RASAL2,RAF1
R-HSA-3781865	Diseases of glycosylation	4/247	102/7349	0.450001780818507	0.75784200110266	0.682405675393957	3955/6385/8818/10418	4	ENSG00000106003,ENSG00000124145,ENSG00000136908,ENSG00000262655	LFNG,SDC4,DPM2,SPON1
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	1/247	18/7349	0.459956674504362	0.75784200110266	0.682405675393957	7316	1	ENSG00000150991	UBC
R-HSA-163359	Glucagon signaling in metabolic regulation	1/247	18/7349	0.459956674504362	0.75784200110266	0.682405675393957	2782	1	ENSG00000078369	GNB1
R-HSA-1643713	Signaling by EGFR in Cancer	1/247	18/7349	0.459956674504362	0.75784200110266	0.682405675393957	7316	1	ENSG00000150991	UBC
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	1/247	18/7349	0.459956674504362	0.75784200110266	0.682405675393957	6777	1	ENSG00000173757	STAT5B
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	1/247	18/7349	0.459956674504362	0.75784200110266	0.682405675393957	10525	1	ENSG00000149428	HYOU1
R-HSA-2514856	The phototransduction cascade	1/247	18/7349	0.459956674504362	0.75784200110266	0.682405675393957	2782	1	ENSG00000078369	GNB1
R-HSA-389357	CD28 dependent PI3K/Akt signaling	1/247	18/7349	0.459956674504362	0.75784200110266	0.682405675393957	3932	1	ENSG00000182866	LCK
R-HSA-418990	Adherens junctions interactions	1/247	18/7349	0.459956674504362	0.75784200110266	0.682405675393957	5817	1	ENSG00000073008	PVR
R-HSA-445095	Interaction between L1 and Ankyrins	1/247	18/7349	0.459956674504362	0.75784200110266	0.682405675393957	3897	1	ENSG00000198910	L1CAM
R-HSA-451326	Activation of kainate receptors upon glutamate binding	1/247	18/7349	0.459956674504362	0.75784200110266	0.682405675393957	2782	1	ENSG00000078369	GNB1
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	1/247	18/7349	0.459956674504362	0.75784200110266	0.682405675393957	7316	1	ENSG00000150991	UBC
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	2/247	46/7349	0.461083996248223	0.758206885775565	0.682734239093636	3955/10418	2	ENSG00000106003,ENSG00000262655	LFNG,SPON1
R-HSA-68882	Mitotic Anaphase	7/247	191/7349	0.462710568870665	0.758558998090127	0.683051301807874	5526/8655/80152/7277/7316/6396/1780	7	ENSG00000068971,ENSG00000088986,ENSG00000102901,ENSG00000127824,ENSG00000150991,ENSG00000157020,ENSG00000158560	PPP2R5B,DYNLL1,CENPT,TUBA4A,UBC,SEC13,DYNC1I1
R-HSA-73864	RNA Polymerase I Transcription	3/247	75/7349	0.464418912426086	0.758558998090127	0.683051301807874	30834/3021/8349	3	ENSG00000066379,ENSG00000132475,ENSG00000184678	ZNRD1,H3F3B,HIST2H2BE
R-HSA-2555396	Mitotic Metaphase and Anaphase	7/247	192/7349	0.468191435810879	0.758558998090127	0.683051301807874	5526/8655/80152/7277/7316/6396/1780	7	ENSG00000068971,ENSG00000088986,ENSG00000102901,ENSG00000127824,ENSG00000150991,ENSG00000157020,ENSG00000158560	PPP2R5B,DYNLL1,CENPT,TUBA4A,UBC,SEC13,DYNC1I1
R-HSA-5620924	Intraflagellar transport	2/247	47/7349	0.472282077753761	0.758558998090127	0.683051301807874	8655/7277	2	ENSG00000088986,ENSG00000127824	DYNLL1,TUBA4A
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	2/247	47/7349	0.472282077753761	0.758558998090127	0.683051301807874	1027/85456	2	ENSG00000111276,ENSG00000149115	CDKN1B,TNKS1BP1
R-HSA-912446	Meiotic recombination	2/247	47/7349	0.472282077753761	0.758558998090127	0.683051301807874	3021/8349	2	ENSG00000132475,ENSG00000184678	H3F3B,HIST2H2BE
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	4/247	105/7349	0.472342575105025	0.758558998090127	0.683051301807874	23480/6727/6730/6734	4	ENSG00000132432,ENSG00000140319,ENSG00000167881,ENSG00000182934	SEC61G,SRP14,SRP68,SRPR
R-HSA-110320	Translesion Synthesis by POLH	1/247	19/7349	0.478152105059187	0.758558998090127	0.683051301807874	7316	1	ENSG00000150991	UBC
R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	1/247	19/7349	0.478152105059187	0.758558998090127	0.683051301807874	55957	1	ENSG00000267796	LIN37
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	1/247	19/7349	0.478152105059187	0.758558998090127	0.683051301807874	51343	1	ENSG00000105325	FZR1
R-HSA-190861	Gap junction assembly	1/247	19/7349	0.478152105059187	0.758558998090127	0.683051301807874	7277	1	ENSG00000127824	TUBA4A
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	1/247	19/7349	0.478152105059187	0.758558998090127	0.683051301807874	1646	1	ENSG00000151632	AKR1C2
R-HSA-399719	Trafficking of AMPA receptors	1/247	19/7349	0.478152105059187	0.758558998090127	0.683051301807874	161	1	ENSG00000183020	AP2A2
R-HSA-399721	Glutamate binding, activation of AMPA receptors and synaptic plasticity	1/247	19/7349	0.478152105059187	0.758558998090127	0.683051301807874	161	1	ENSG00000183020	AP2A2
R-HSA-5218921	VEGFR2 mediated cell proliferation	1/247	19/7349	0.478152105059187	0.758558998090127	0.683051301807874	8877	1	ENSG00000176170	SPHK1
R-HSA-6804760	Regulation of TP53 Activity through Methylation	1/247	19/7349	0.478152105059187	0.758558998090127	0.683051301807874	7316	1	ENSG00000150991	UBC
R-HSA-1236974	ER-Phagosome pathway	3/247	77/7349	0.481823553432712	0.758558998090127	0.683051301807874	23480/7316/8517	3	ENSG00000132432,ENSG00000150991,ENSG00000269335	SEC61G,UBC,IKBKG
R-HSA-5693607	Processing of DNA double-strand break ends	3/247	77/7349	0.481823553432712	0.758558998090127	0.683051301807874	9025/7316/8349	3	ENSG00000112130,ENSG00000150991,ENSG00000184678	RNF8,UBC,HIST2H2BE
R-HSA-68886	M Phase	12/247	342/7349	0.481878103768201	0.758558998090127	0.683051301807874	27175/5526/8655/80152/7277/3021/7316/6396/1780/5116/8349/9814	12	ENSG00000037042,ENSG00000068971,ENSG00000088986,ENSG00000102901,ENSG00000127824,ENSG00000132475,ENSG00000150991,ENSG00000157020,ENSG00000158560,ENSG00000160299,ENSG00000184678,ENSG00000198089	TUBG2,PPP2R5B,DYNLL1,CENPT,TUBA4A,H3F3B,UBC,SEC13,DYNC1I1,PCNT,HIST2H2BE,SFI1
R-HSA-425366	Transport of bile salts and organic acids, metal ions and amine compounds	2/247	48/7349	0.483339704835309	0.758558998090127	0.683051301807874	284111/55630	2	ENSG00000141485,ENSG00000147804	SLC13A5,SLC39A4
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	2/247	48/7349	0.483339704835309	0.758558998090127	0.683051301807874	7316/51255	2	ENSG00000150991,ENSG00000168894	UBC,RNF181
R-HSA-5668914	Diseases of metabolism	3/247	78/7349	0.490425966938956	0.758558998090127	0.683051301807874	3423/8029/7316	3	ENSG00000010404,ENSG00000107611,ENSG00000150991	IDS,CUBN,UBC
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	2/247	49/7349	0.494253644345185	0.758558998090127	0.683051301807874	8818/4241	2	ENSG00000136908,ENSG00000163975	DPM2,MFI2
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	2/247	49/7349	0.494253644345185	0.758558998090127	0.683051301807874	1027/8349	2	ENSG00000111276,ENSG00000184678	CDKN1B,HIST2H2BE
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	2/247	49/7349	0.494253644345185	0.758558998090127	0.683051301807874	9025/8349	2	ENSG00000112130,ENSG00000184678	RNF8,HIST2H2BE
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	2/247	49/7349	0.494253644345185	0.758558998090127	0.683051301807874	80152/8349	2	ENSG00000102901,ENSG00000184678	CENPT,HIST2H2BE
R-HSA-774815	Nucleosome assembly	2/247	49/7349	0.494253644345185	0.758558998090127	0.683051301807874	80152/8349	2	ENSG00000102901,ENSG00000184678	CENPT,HIST2H2BE
R-HSA-114508	Effects of PIP2 hydrolysis	1/247	20/7349	0.495736884056511	0.758558998090127	0.683051301807874	10235	1	ENSG00000068831	RASGRP2
R-HSA-210991	Basigin interactions	1/247	20/7349	0.495736884056511	0.758558998090127	0.683051301807874	3897	1	ENSG00000198910	L1CAM
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	1/247	20/7349	0.495736884056511	0.758558998090127	0.683051301807874	7316	1	ENSG00000150991	UBC
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	1/247	20/7349	0.495736884056511	0.758558998090127	0.683051301807874	7277	1	ENSG00000127824	TUBA4A
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	1/247	20/7349	0.495736884056511	0.758558998090127	0.683051301807874	7316	1	ENSG00000150991	UBC
R-HSA-5654726	Negative regulation of FGFR1 signaling	1/247	20/7349	0.495736884056511	0.758558998090127	0.683051301807874	7316	1	ENSG00000150991	UBC
R-HSA-5654732	Negative regulation of FGFR3 signaling	1/247	20/7349	0.495736884056511	0.758558998090127	0.683051301807874	7316	1	ENSG00000150991	UBC
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	1/247	20/7349	0.495736884056511	0.758558998090127	0.683051301807874	85456	1	ENSG00000149115	TNKS1BP1
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	1/247	20/7349	0.495736884056511	0.758558998090127	0.683051301807874	3725	1	ENSG00000177606	JUN
R-HSA-8863678	Neurodegenerative Diseases	1/247	20/7349	0.495736884056511	0.758558998090127	0.683051301807874	3725	1	ENSG00000177606	JUN
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	1/247	20/7349	0.495736884056511	0.758558998090127	0.683051301807874	2530	1	ENSG00000033170	FUT8
R-HSA-1474165	Reproduction	3/247	79/7349	0.498958483383616	0.759568500208876	0.68396031710942	23345/3021/8349	3	ENSG00000131018,ENSG00000132475,ENSG00000184678	SYNE1,H3F3B,HIST2H2BE
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	3/247	80/7349	0.507418812047355	0.759568500208876	0.68396031710942	51586/5970/10025	3	ENSG00000099917,ENSG00000173039,ENSG00000175221	MED15,RELA,MED16
R-HSA-69202	Cyclin E associated events during G1/S transition 	3/247	80/7349	0.507418812047355	0.759568500208876	0.68396031710942	1027/7316/55957	3	ENSG00000111276,ENSG00000150991,ENSG00000267796	CDKN1B,UBC,LIN37
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	4/247	110/7349	0.508794950483725	0.759568500208876	0.68396031710942	2067/9025/7316/8349	4	ENSG00000012061,ENSG00000112130,ENSG00000150991,ENSG00000184678	ERCC1,RNF8,UBC,HIST2H2BE
R-HSA-418594	G alpha (i) signalling events	6/247	170/7349	0.510713683885013	0.759568500208876	0.68396031710942	23596/2782/2771/6385/301/5499	6	ENSG00000054277,ENSG00000078369,ENSG00000114353,ENSG00000124145,ENSG00000135046,ENSG00000172531	OPN3,GNB1,GNAI2,SDC4,ANXA1,PPP1CA
R-HSA-112409	RAF-independent MAPK1/3 activation	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	11221	1	ENSG00000143507	DUSP10
R-HSA-1266695	Interleukin-7 signaling	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	6777	1	ENSG00000173757	STAT5B
R-HSA-2424491	DAP12 signaling	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	3932	1	ENSG00000182866	LCK
R-HSA-3000170	Syndecan interactions	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	6385	1	ENSG00000124145	SDC4
R-HSA-3296482	Defects in vitamin and cofactor metabolism	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	8029	1	ENSG00000107611	CUBN
R-HSA-375170	CDO in myogenesis	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	5600	1	ENSG00000185386	MAPK11
R-HSA-379726	Mitochondrial tRNA aminoacylation	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	23438	1	ENSG00000112855	HARS2
R-HSA-525793	Myogenesis	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	5600	1	ENSG00000185386	MAPK11
R-HSA-5654727	Negative regulation of FGFR2 signaling	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	7316	1	ENSG00000150991	UBC
R-HSA-5654733	Negative regulation of FGFR4 signaling	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	7316	1	ENSG00000150991	UBC
R-HSA-8863795	Downregulation of ERBB2 signaling	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	7316	1	ENSG00000150991	UBC
R-HSA-901032	ER Quality Control Compartment (ERQC)	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	7316	1	ENSG00000150991	UBC
R-HSA-912631	Regulation of signaling by CBL	1/247	21/7349	0.51273142487218	0.759568500208876	0.68396031710942	7316	1	ENSG00000150991	UBC
R-HSA-909733	Interferon alpha/beta signaling	2/247	51/7349	0.515639375136214	0.761643648825174	0.685828903425548	3664/9021	2	ENSG00000117595,ENSG00000184557	IRF6,SOCS3
R-HSA-212165	Epigenetic regulation of gene expression	4/247	111/7349	0.51595214920415	0.761643648825174	0.685828903425548	30834/23309/3021/8349	4	ENSG00000066379,ENSG00000127511,ENSG00000132475,ENSG00000184678	ZNRD1,SIN3B,H3F3B,HIST2H2BE
R-HSA-1614635	Sulfur amino acid metabolism	1/247	22/7349	0.529155461179027	0.771608224750602	0.694801595826487	58472	1	ENSG00000137767	SQRDL
R-HSA-1839124	FGFR1 mutant receptor activation	1/247	22/7349	0.529155461179027	0.771608224750602	0.694801595826487	6777	1	ENSG00000173757	STAT5B
R-HSA-191273	Cholesterol biosynthesis	1/247	22/7349	0.529155461179027	0.771608224750602	0.694801595826487	10682	1	ENSG00000147155	EBP
R-HSA-2172127	DAP12 interactions	1/247	22/7349	0.529155461179027	0.771608224750602	0.694801595826487	3932	1	ENSG00000182866	LCK
R-HSA-425410	Metal ion SLC transporters	1/247	22/7349	0.529155461179027	0.771608224750602	0.694801595826487	55630	1	ENSG00000147804	SLC39A4
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	1/247	22/7349	0.529155461179027	0.771608224750602	0.694801595826487	10418	1	ENSG00000262655	SPON1
R-HSA-5627123	RHO GTPases activate PAKs	1/247	22/7349	0.529155461179027	0.771608224750602	0.694801595826487	4637	1	ENSG00000092841	MYL6
R-HSA-5687128	MAPK6/MAPK4 signaling	3/247	83/7349	0.532345822571455	0.774910353899666	0.697775027846521	3315/7316/3725	3	ENSG00000106211,ENSG00000150991,ENSG00000177606	HSPB1,UBC,JUN
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	2/247	53/7349	0.536420502242025	0.77813511330429	0.700678791581301	51343/7316	2	ENSG00000105325,ENSG00000150991	FZR1,UBC
R-HSA-4641258	Degradation of DVL	2/247	53/7349	0.536420502242025	0.77813511330429	0.700678791581301	1855/7316	2	ENSG00000107404,ENSG00000150991	DVL1,UBC
R-HSA-1222556	ROS, RNS production in phagocytes	1/247	23/7349	0.54502806948922	0.780411937264125	0.702728978282228	4688	1	ENSG00000116701	NCF2
R-HSA-1482839	Acyl chain remodelling of PE	1/247	23/7349	0.54502806948922	0.780411937264125	0.702728978282228	63874	1	ENSG00000100439	ABHD4
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	1/247	23/7349	0.54502806948922	0.780411937264125	0.702728978282228	7316	1	ENSG00000150991	UBC
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	1/247	23/7349	0.54502806948922	0.780411937264125	0.702728978282228	7316	1	ENSG00000150991	UBC
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	1/247	23/7349	0.54502806948922	0.780411937264125	0.702728978282228	10418	1	ENSG00000262655	SPON1
R-HSA-9013507	NOTCH3 Activation and Transmission of Signal to the Nucleus	1/247	23/7349	0.54502806948922	0.780411937264125	0.702728978282228	7316	1	ENSG00000150991	UBC
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	1/247	23/7349	0.54502806948922	0.780411937264125	0.702728978282228	6396	1	ENSG00000157020	SEC13
R-HSA-69620	Cell Cycle Checkpoints	9/247	267/7349	0.545449203464173	0.780411937264125	0.702728978282228	5526/8655/80152/1027/9025/7316/6396/1780/8349	9	ENSG00000068971,ENSG00000088986,ENSG00000102901,ENSG00000111276,ENSG00000112130,ENSG00000150991,ENSG00000157020,ENSG00000158560,ENSG00000184678	PPP2R5B,DYNLL1,CENPT,CDKN1B,RNF8,UBC,SEC13,DYNC1I1,HIST2H2BE
R-HSA-5693538	Homology Directed Repair	4/247	116/7349	0.55098765371531	0.786990897883471	0.708653062798925	2067/9025/7316/8349	4	ENSG00000012061,ENSG00000112130,ENSG00000150991,ENSG00000184678	ERCC1,RNF8,UBC,HIST2H2BE
R-HSA-2187338	Visual phototransduction	2/247	55/7349	0.556583269538867	0.788281945087067	0.709815597915286	2782/6385	2	ENSG00000078369,ENSG00000124145	GNB1,SDC4
R-HSA-8873719	RAB geranylgeranylation	2/247	55/7349	0.556583269538867	0.788281945087067	0.709815597915286	11021/116442	2	ENSG00000111737,ENSG00000155961	RAB35,RAB39B
R-HSA-180024	DARPP-32 events	1/247	24/7349	0.560367690951977	0.788281945087067	0.709815597915286	5499	1	ENSG00000172531	PPP1CA
R-HSA-352230	Amino acid transport across the plasma membrane	1/247	24/7349	0.560367690951977	0.788281945087067	0.709815597915286	120103	1	ENSG00000180773	SLC36A4
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	1/247	24/7349	0.560367690951977	0.788281945087067	0.709815597915286	2782	1	ENSG00000078369	GNB1
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	1/247	24/7349	0.560367690951977	0.788281945087067	0.709815597915286	7277	1	ENSG00000127824	TUBA4A
R-HSA-4085001	Sialic acid metabolism	1/247	24/7349	0.560367690951977	0.788281945087067	0.709815597915286	30815	1	ENSG00000160408	ST6GALNAC6
R-HSA-5339562	Uptake and actions of bacterial toxins	1/247	24/7349	0.560367690951977	0.788281945087067	0.709815597915286	5045	1	ENSG00000140564	FURIN
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	1/247	24/7349	0.560367690951977	0.788281945087067	0.709815597915286	1027	1	ENSG00000111276	CDKN1B
R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	3/247	88/7349	0.572271901059686	0.79704308214549	0.717704642917904	3021/7316/8349	3	ENSG00000132475,ENSG00000150991,ENSG00000184678	H3F3B,UBC,HIST2H2BE
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	1/247	25/7349	0.575192152431139	0.79704308214549	0.717704642917904	7316	1	ENSG00000150991	UBC
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	1/247	25/7349	0.575192152431139	0.79704308214549	0.717704642917904	6385	1	ENSG00000124145	SDC4
R-HSA-429947	Deadenylation of mRNA	1/247	25/7349	0.575192152431139	0.79704308214549	0.717704642917904	85456	1	ENSG00000149115	TNKS1BP1
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	1/247	25/7349	0.575192152431139	0.79704308214549	0.717704642917904	2782	1	ENSG00000078369	GNB1
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	1/247	25/7349	0.575192152431139	0.79704308214549	0.717704642917904	7316	1	ENSG00000150991	UBC
R-HSA-70268	Pyruvate metabolism	1/247	25/7349	0.575192152431139	0.79704308214549	0.717704642917904	5467	1	ENSG00000112033	PPARD
R-HSA-8982491	Glycogen metabolism	1/247	25/7349	0.575192152431139	0.79704308214549	0.717704642917904	7316	1	ENSG00000150991	UBC
R-HSA-901042	Calnexin/calreticulin cycle	1/247	25/7349	0.575192152431139	0.79704308214549	0.717704642917904	7316	1	ENSG00000150991	UBC
R-HSA-9033241	Peroxisomal protein import	2/247	57/7349	0.576118356867409	0.79704308214549	0.717704642917904	7316/122970	2	ENSG00000150991,ENSG00000177465	UBC,ACOT4
R-HSA-1483257	Phospholipid metabolism	6/247	184/7349	0.588903428867296	0.797135930410053	0.717788248976417	8897/63874/56261/375/55361/23396	6	ENSG00000100330,ENSG00000100439,ENSG00000125772,ENSG00000143761,ENSG00000155252,ENSG00000186111	MTMR3,ABHD4,GPCPD1,ARF1,PI4K2A,PIP5K1C
R-HSA-425407	SLC-mediated transmembrane transport	5/247	153/7349	0.589468926968337	0.797135930410053	0.717788248976417	6560/284111/55630/10999/120103	5	ENSG00000124067,ENSG00000141485,ENSG00000147804,ENSG00000167114,ENSG00000180773	SLC12A4,SLC13A5,SLC39A4,SLC27A4,SLC36A4
R-HSA-913531	Interferon Signaling	5/247	153/7349	0.589468926968337	0.797135930410053	0.717788248976417	3664/7316/80128/9021/402569	5	ENSG00000117595,ENSG00000150991,ENSG00000163462,ENSG00000184557,ENSG00000185467	IRF6,UBC,TRIM46,SOCS3,KPNA7
R-HSA-1538133	G0 and Early G1	1/247	26/7349	0.589518686886288	0.797135930410053	0.717788248976417	55957	1	ENSG00000267796	LIN37
R-HSA-171306	Packaging Of Telomere Ends	1/247	26/7349	0.589518686886288	0.797135930410053	0.717788248976417	8349	1	ENSG00000184678	HIST2H2BE
R-HSA-192105	Synthesis of bile acids and bile salts	1/247	26/7349	0.589518686886288	0.797135930410053	0.717788248976417	1646	1	ENSG00000151632	AKR1C2
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	1/247	26/7349	0.589518686886288	0.797135930410053	0.717788248976417	7316	1	ENSG00000150991	UBC
R-HSA-2129379	Molecules associated with elastic fibres	1/247	26/7349	0.589518686886288	0.797135930410053	0.717788248976417	4054	1	ENSG00000168056	LTBP3
R-HSA-390918	Peroxisomal lipid metabolism	1/247	26/7349	0.589518686886288	0.797135930410053	0.717788248976417	122970	1	ENSG00000177465	ACOT4
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	1/247	26/7349	0.589518686886288	0.797135930410053	0.717788248976417	10999	1	ENSG00000167114	SLC27A4
R-HSA-5626467	RHO GTPases activate IQGAPs	1/247	26/7349	0.589518686886288	0.797135930410053	0.717788248976417	7277	1	ENSG00000127824	TUBA4A
R-HSA-5689901	Metalloprotease DUBs	1/247	26/7349	0.589518686886288	0.797135930410053	0.717788248976417	7316	1	ENSG00000150991	UBC
R-HSA-6803529	FGFR2 alternative splicing	1/247	26/7349	0.589518686886288	0.797135930410053	0.717788248976417	7072	1	ENSG00000116001	TIA1
R-HSA-975634	Retinoid metabolism and transport	1/247	26/7349	0.589518686886288	0.797135930410053	0.717788248976417	6385	1	ENSG00000124145	SDC4
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	2/247	59/7349	0.595020357961879	0.80069459745031	0.720992682857854	1027/7316	2	ENSG00000111276,ENSG00000150991	CDKN1B,UBC
R-HSA-5358346	Hedgehog ligand biogenesis	2/247	59/7349	0.595020357961879	0.80069459745031	0.720992682857854	7316/5034	2	ENSG00000150991,ENSG00000185624	UBC,P4HB
R-HSA-5654738	Signaling by FGFR2	2/247	59/7349	0.595020357961879	0.80069459745031	0.720992682857854	7072/7316	2	ENSG00000116001,ENSG00000150991	TIA1,UBC
R-HSA-186763	Downstream signal transduction	1/247	27/7349	0.603363953080346	0.801494771193734	0.721713206532999	6777	1	ENSG00000173757	STAT5B
R-HSA-187687	Signalling to ERKs	1/247	27/7349	0.603363953080346	0.801494771193734	0.721713206532999	5600	1	ENSG00000185386	MAPK11
R-HSA-389356	CD28 co-stimulation	1/247	27/7349	0.603363953080346	0.801494771193734	0.721713206532999	3932	1	ENSG00000182866	LCK
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	1/247	27/7349	0.603363953080346	0.801494771193734	0.721713206532999	7277	1	ENSG00000127824	TUBA4A
R-HSA-5205647	Mitophagy	1/247	27/7349	0.603363953080346	0.801494771193734	0.721713206532999	7316	1	ENSG00000150991	UBC
R-HSA-539107	Activation of E2F1 target genes at G1/S	1/247	27/7349	0.603363953080346	0.801494771193734	0.721713206532999	55957	1	ENSG00000267796	LIN37
R-HSA-6783783	Interleukin-10 signaling	1/247	27/7349	0.603363953080346	0.801494771193734	0.721713206532999	1437	1	ENSG00000164400	CSF2
R-HSA-69205	G1/S-Specific Transcription	1/247	27/7349	0.603363953080346	0.801494771193734	0.721713206532999	55957	1	ENSG00000267796	LIN37
R-HSA-2219528	PI3K/AKT Signaling in Cancer	2/247	60/7349	0.60423321460364	0.801494771193734	0.721713206532999	1027/3932	2	ENSG00000111276,ENSG00000182866	CDKN1B,LCK
R-HSA-5663205	Infectious disease	11/247	343/7349	0.608504645053663	0.805883525173917	0.725665099697573	8907/5045/375/7316/51271/55690/3932/161/9146/402569/3303	11	ENSG00000072958,ENSG00000140564,ENSG00000143761,ENSG00000150991,ENSG00000165006,ENSG00000175115,ENSG00000182866,ENSG00000183020,ENSG00000185359,ENSG00000185467,ENSG00000204389	AP1M1,FURIN,ARF1,UBC,UBAP1,PACS1,LCK,AP2A2,HGS,KPNA7,HSPA1A
R-HSA-4608870	Asymmetric localization of PCP proteins	2/247	61/7349	0.613287307562552	0.810384260172964	0.729717827182094	7316/23513	2	ENSG00000150991,ENSG00000180900	UBC,SCRIB
R-HSA-114452	Activation of BH3-only proteins	1/247	28/7349	0.616744054635816	0.810384260172964	0.729717827182094	8655	1	ENSG00000088986	DYNLL1
R-HSA-1980145	Signaling by NOTCH2	1/247	28/7349	0.616744054635816	0.810384260172964	0.729717827182094	7316	1	ENSG00000150991	UBC
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	1/247	28/7349	0.616744054635816	0.810384260172964	0.729717827182094	93659	1	ENSG00000189052,ENSG00000213030	CGB5,CGB8
R-HSA-8955332	Carboxyterminal post-translational modifications of tubulin	1/247	28/7349	0.616744054635816	0.810384260172964	0.729717827182094	7277	1	ENSG00000127824	TUBA4A
R-HSA-5663202	Diseases of signal transduction	10/247	315/7349	0.620259079545157	0.813725469560025	0.73272644935544	5526/9462/64840/22943/1027/5894/7316/1487/6777/3932	10	ENSG00000068971,ENSG00000075391,ENSG00000102312,ENSG00000107984,ENSG00000111276,ENSG00000132155,ENSG00000150991,ENSG00000159692,ENSG00000173757,ENSG00000182866	PPP2R5B,RASAL2,PORCN,DKK1,CDKN1B,RAF1,UBC,CTBP1,STAT5B,LCK
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	2/247	62/7349	0.622182858649469	0.814971913442262	0.733848821008187	7316/112398	2	ENSG00000150991,ENSG00000269858	UBC,EGLN2
R-HSA-112310	Neurotransmitter release cycle	1/247	29/7349	0.629674558461107	0.816198225974846	0.734953065205294	6812	1	ENSG00000136854	STXBP1
R-HSA-445717	Aquaporin-mediated transport	1/247	29/7349	0.629674558461107	0.816198225974846	0.734953065205294	2782	1	ENSG00000078369	GNB1
R-HSA-5655302	Signaling by FGFR1 in disease	1/247	29/7349	0.629674558461107	0.816198225974846	0.734953065205294	6777	1	ENSG00000173757	STAT5B
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	1/247	29/7349	0.629674558461107	0.816198225974846	0.734953065205294	5894	1	ENSG00000132155	RAF1
R-HSA-6806667	Metabolism of fat-soluble vitamins	1/247	29/7349	0.629674558461107	0.816198225974846	0.734953065205294	6385	1	ENSG00000124145	SDC4
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	2/247	63/7349	0.630920253531332	0.816198225974846	0.734953065205294	51343/7316	2	ENSG00000105325,ENSG00000150991	FZR1,UBC
R-HSA-69563	p53-Dependent G1 DNA Damage Response	2/247	63/7349	0.630920253531332	0.816198225974846	0.734953065205294	1027/7316	2	ENSG00000111276,ENSG00000150991	CDKN1B,UBC
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	2/247	63/7349	0.630920253531332	0.816198225974846	0.734953065205294	1027/7316	2	ENSG00000111276,ENSG00000150991	CDKN1B,UBC
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	1/247	30/7349	0.642170512567679	0.824181523243497	0.742141697343072	7316	1	ENSG00000150991	UBC
R-HSA-190828	Gap junction trafficking	1/247	30/7349	0.642170512567679	0.824181523243497	0.742141697343072	7277	1	ENSG00000127824	TUBA4A
R-HSA-194068	Bile acid and bile salt metabolism	1/247	30/7349	0.642170512567679	0.824181523243497	0.742141697343072	1646	1	ENSG00000151632	AKR1C2
R-HSA-73772	RNA Polymerase I Promoter Escape	1/247	30/7349	0.642170512567679	0.824181523243497	0.742141697343072	30834	1	ENSG00000066379	ZNRD1
R-HSA-69278	Cell Cycle, Mitotic	15/247	477/7349	0.645020557833571	0.824181523243497	0.742141697343072	27175/5526/8655/80152/51343/1027/7277/3021/7316/6396/1780/5116/8349/9814/55957	15	ENSG00000037042,ENSG00000068971,ENSG00000088986,ENSG00000102901,ENSG00000105325,ENSG00000111276,ENSG00000127824,ENSG00000132475,ENSG00000150991,ENSG00000157020,ENSG00000158560,ENSG00000160299,ENSG00000184678,ENSG00000198089,ENSG00000267796	TUBG2,PPP2R5B,DYNLL1,CENPT,FZR1,CDKN1B,TUBA4A,H3F3B,UBC,SEC13,DYNC1I1,PCNT,HIST2H2BE,SFI1,LIN37
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	3/247	98/7349	0.645506432866595	0.824181523243497	0.742141697343072	23596/301/136	3	ENSG00000054277,ENSG00000135046,ENSG00000170425	OPN3,ANXA1,ADORA2B
R-HSA-3247509	Chromatin modifying enzymes	7/247	227/7349	0.646419236747159	0.824181523243497	0.742141697343072	4791/51147/55683/84787/10474/5970/8349	7	ENSG00000077150,ENSG00000111653,ENSG00000114982,ENSG00000133247,ENSG00000171148,ENSG00000173039,ENSG00000184678	NFKB2,ING4,KANSL3,SUV420H2,TADA3,RELA,HIST2H2BE
R-HSA-4839726	Chromatin organization	7/247	227/7349	0.646419236747159	0.824181523243497	0.742141697343072	4791/51147/55683/84787/10474/5970/8349	7	ENSG00000077150,ENSG00000111653,ENSG00000114982,ENSG00000133247,ENSG00000171148,ENSG00000173039,ENSG00000184678	NFKB2,ING4,KANSL3,SUV420H2,TADA3,RELA,HIST2H2BE
R-HSA-1980143	Signaling by NOTCH1	2/247	65/7349	0.647922870124517	0.824181523243497	0.742141697343072	7090/7316	2	ENSG00000140332,ENSG00000150991	TLE3,UBC
R-HSA-5658442	Regulation of RAS by GAPs	2/247	65/7349	0.647922870124517	0.824181523243497	0.742141697343072	9462/7316	2	ENSG00000075391,ENSG00000150991	RASAL2,UBC
R-HSA-69615	G1/S DNA Damage Checkpoints	2/247	65/7349	0.647922870124517	0.824181523243497	0.742141697343072	1027/7316	2	ENSG00000111276,ENSG00000150991	CDKN1B,UBC
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	1/247	31/7349	0.654246463298077	0.824705255693509	0.742613296958502	3303	1	ENSG00000204389	HSPA1A
R-HSA-1912408	Pre-NOTCH Transcription and Translation	1/247	31/7349	0.654246463298077	0.824705255693509	0.742613296958502	3725	1	ENSG00000177606	JUN
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	1/247	31/7349	0.654246463298077	0.824705255693509	0.742613296958502	7316	1	ENSG00000150991	UBC
R-HSA-5654741	Signaling by FGFR3	1/247	31/7349	0.654246463298077	0.824705255693509	0.742613296958502	7316	1	ENSG00000150991	UBC
R-HSA-5654743	Signaling by FGFR4	1/247	31/7349	0.654246463298077	0.824705255693509	0.742613296958502	7316	1	ENSG00000150991	UBC
R-HSA-73863	RNA Polymerase I Transcription Termination	1/247	31/7349	0.654246463298077	0.824705255693509	0.742613296958502	30834	1	ENSG00000066379	ZNRD1
R-HSA-6782135	Dual incision in TC-NER	2/247	66/7349	0.656189584633674	0.82591080050885	0.743698840677025	2067/7316	2	ENSG00000012061,ENSG00000150991	ERCC1,UBC
R-HSA-6807070	PTEN Regulation	4/247	133/7349	0.659194321683384	0.828190322512352	0.745751456855743	6591/7316/3725/84232	4	ENSG00000019549,ENSG00000150991,ENSG00000177606,ENSG00000179632	SNAI2,UBC,JUN,MAF1
R-HSA-6802957	Oncogenic MAPK signaling	2/247	67/7349	0.664301108885555	0.828190322512352	0.745751456855743	9462/5894	2	ENSG00000075391,ENSG00000132155	RASAL2,RAF1
R-HSA-112043	PLC beta mediated events	1/247	32/7349	0.665916471984245	0.828190322512352	0.745751456855743	2771	1	ENSG00000114353	GNAI2
R-HSA-1236394	Signaling by ERBB4	1/247	32/7349	0.665916471984245	0.828190322512352	0.745751456855743	7316	1	ENSG00000150991	UBC
R-HSA-157858	Gap junction trafficking and regulation	1/247	32/7349	0.665916471984245	0.828190322512352	0.745751456855743	7277	1	ENSG00000127824	TUBA4A
R-HSA-5362517	Signaling by Retinoic Acid	1/247	32/7349	0.665916471984245	0.828190322512352	0.745751456855743	5467	1	ENSG00000112033	PPARD
R-HSA-5656169	Termination of translesion DNA synthesis	1/247	32/7349	0.665916471984245	0.828190322512352	0.745751456855743	7316	1	ENSG00000150991	UBC
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	1/247	32/7349	0.665916471984245	0.828190322512352	0.745751456855743	7220	1	ENSG00000144935	TRPC1
R-HSA-190236	Signaling by FGFR	2/247	68/7349	0.672258491020735	0.832273828227741	0.749428486463011	7072/7316	2	ENSG00000116001,ENSG00000150991	TIA1,UBC
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	2/247	68/7349	0.672258491020735	0.832273828227741	0.749428486463011	6560/120103	2	ENSG00000124067,ENSG00000180773	SLC12A4,SLC36A4
R-HSA-5578749	Transcriptional regulation by small RNAs	2/247	68/7349	0.672258491020735	0.832273828227741	0.749428486463011	3021/8349	2	ENSG00000132475,ENSG00000184678	H3F3B,HIST2H2BE
R-HSA-112040	G-protein mediated events	1/247	33/7349	0.677194131054887	0.832273828227741	0.749428486463011	2771	1	ENSG00000114353	GNAI2
R-HSA-1296071	Potassium Channels	1/247	33/7349	0.677194131054887	0.832273828227741	0.749428486463011	2782	1	ENSG00000078369	GNB1
R-HSA-5674135	MAP2K and MAPK activation	1/247	33/7349	0.677194131054887	0.832273828227741	0.749428486463011	5894	1	ENSG00000132155	RAF1
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	1/247	33/7349	0.677194131054887	0.832273828227741	0.749428486463011	5894	1	ENSG00000132155	RAF1
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	1/247	33/7349	0.677194131054887	0.832273828227741	0.749428486463011	5894	1	ENSG00000132155	RAF1
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	2/247	69/7349	0.680062883905532	0.832273828227741	0.749428486463011	51343/7316	2	ENSG00000105325,ENSG00000150991	FZR1,UBC
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	2/247	69/7349	0.680062883905532	0.832273828227741	0.749428486463011	7277/7316	2	ENSG00000127824,ENSG00000150991	TUBA4A,UBC
R-HSA-1169408	ISG15 antiviral mechanism	2/247	70/7349	0.687715536968263	0.832273828227741	0.749428486463011	7316/402569	2	ENSG00000150991,ENSG00000185467	UBC,KPNA7
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	2/247	70/7349	0.687715536968263	0.832273828227741	0.749428486463011	7316/402569	2	ENSG00000150991,ENSG00000185467	UBC,KPNA7
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	2/247	70/7349	0.687715536968263	0.832273828227741	0.749428486463011	7316/112398	2	ENSG00000150991,ENSG00000269858	UBC,EGLN2
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	2/247	70/7349	0.687715536968263	0.832273828227741	0.749428486463011	51343/7316	2	ENSG00000105325,ENSG00000150991	FZR1,UBC
R-HSA-211945	Phase I - Functionalization of compounds	2/247	70/7349	0.687715536968263	0.832273828227741	0.749428486463011	54498/9049	2	ENSG00000088826,ENSG00000110711	SMOX,AIP
R-HSA-2262749	Cellular response to hypoxia	2/247	70/7349	0.687715536968263	0.832273828227741	0.749428486463011	7316/112398	2	ENSG00000150991,ENSG00000269858	UBC,EGLN2
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	1/247	34/7349	0.688092579610032	0.832273828227741	0.749428486463011	5045	1	ENSG00000140564	FURIN
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1/247	34/7349	0.688092579610032	0.832273828227741	0.749428486463011	7316	1	ENSG00000150991	UBC
R-HSA-6804757	Regulation of TP53 Degradation	1/247	34/7349	0.688092579610032	0.832273828227741	0.749428486463011	7316	1	ENSG00000150991	UBC
R-HSA-5619115	Disorders of transmembrane transporters	3/247	105/7349	0.691255631754619	0.834893165625708	0.751787092483188	55630/7316/10999	3	ENSG00000147804,ENSG00000150991,ENSG00000167114	SLC39A4,UBC,SLC27A4
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	1/247	35/7349	0.698624518480343	0.840156209724206	0.756526248082162	3932	1	ENSG00000182866	LCK
R-HSA-5654736	Signaling by FGFR1	1/247	35/7349	0.698624518480343	0.840156209724206	0.756526248082162	7316	1	ENSG00000150991	UBC
R-HSA-6806003	Regulation of TP53 Expression and Degradation	1/247	35/7349	0.698624518480343	0.840156209724206	0.756526248082162	7316	1	ENSG00000150991	UBC
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	3/247	107/7349	0.703485249466196	0.84373945713886	0.759752815583756	51586/23309/10025	3	ENSG00000099917,ENSG00000127511,ENSG00000175221	MED15,SIN3B,MED16
R-HSA-5693532	DNA Double-Strand Break Repair	4/247	141/7349	0.703620240242443	0.84373945713886	0.759752815583756	2067/9025/7316/8349	4	ENSG00000012061,ENSG00000112130,ENSG00000150991,ENSG00000184678	ERCC1,RNF8,UBC,HIST2H2BE
R-HSA-421270	Cell-cell junction organization	1/247	37/7349	0.718637566026681	0.859285203949046	0.773751123721961	5817	1	ENSG00000073008	PVR
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	1/247	37/7349	0.718637566026681	0.859285203949046	0.773751123721961	2067	1	ENSG00000012061	ERCC1
R-HSA-69473	G2/M DNA damage checkpoint	2/247	75/7349	0.723752252961012	0.864166384776558	0.778146427089248	9025/8349	2	ENSG00000112130,ENSG00000184678	RNF8,HIST2H2BE
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	1/247	38/7349	0.728142013673209	0.864474986446065	0.77842431025012	7316	1	ENSG00000150991	UBC
R-HSA-1660661	Sphingolipid de novo biosynthesis	1/247	38/7349	0.728142013673209	0.864474986446065	0.77842431025012	8877	1	ENSG00000176170	SPHK1
R-HSA-168276	NS1 Mediated Effects on Host Pathways	1/247	38/7349	0.728142013673209	0.864474986446065	0.77842431025012	402569	1	ENSG00000185467	KPNA7
R-HSA-5696394	DNA Damage Recognition in GG-NER	1/247	38/7349	0.728142013673209	0.864474986446065	0.77842431025012	7316	1	ENSG00000150991	UBC
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	2/247	77/7349	0.73715723105478	0.87290298637398	0.78601337891438	51343/7316	2	ENSG00000105325,ENSG00000150991	FZR1,UBC
R-HSA-3000178	ECM proteoglycans	1/247	39/7349	0.737326656351737	0.87290298637398	0.78601337891438	3911	1	ENSG00000130702	LAMA5
R-HSA-168253	Host Interactions with Influenza Factors	1/247	40/7349	0.746202212559825	0.880918549947212	0.793231065537576	402569	1	ENSG00000185467	KPNA7
R-HSA-8854214	TBC/RABGAPs	1/247	40/7349	0.746202212559825	0.880918549947212	0.793231065537576	11021	1	ENSG00000111737	RAB35
R-HSA-428157	Sphingolipid metabolism	2/247	79/7349	0.750005786997418	0.882918204946327	0.795031672944187	8706/8877	2	ENSG00000169255,ENSG00000176170	B3GALNT1,SPHK1
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	2/247	79/7349	0.750005786997418	0.882918204946327	0.795031672944187	2067/7316	2	ENSG00000012061,ENSG00000150991	ERCC1,UBC
R-HSA-109606	Intrinsic Pathway for Apoptosis	1/247	41/7349	0.75477904297407	0.884804004158679	0.79672975787916	8655	1	ENSG00000088986	DYNLL1
R-HSA-1660662	Glycosphingolipid metabolism	1/247	41/7349	0.75477904297407	0.884804004158679	0.79672975787916	8706	1	ENSG00000169255	B3GALNT1
R-HSA-9012852	Signaling by NOTCH3	1/247	41/7349	0.75477904297407	0.884804004158679	0.79672975787916	7316	1	ENSG00000150991	UBC
R-HSA-1227986	Signaling by ERBB2	1/247	42/7349	0.763067162348099	0.889536510982395	0.800991186396774	7316	1	ENSG00000150991	UBC
R-HSA-2142753	Arachidonic acid metabolism	1/247	42/7349	0.763067162348099	0.889536510982395	0.800991186396774	2879	1	ENSG00000167468	GPX4
R-HSA-379724	tRNA Aminoacylation	1/247	42/7349	0.763067162348099	0.889536510982395	0.800991186396774	23438	1	ENSG00000112855	HARS2
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	1/247	42/7349	0.763067162348099	0.889536510982395	0.800991186396774	161	1	ENSG00000183020	AP2A2
R-HSA-3371556	Cellular response to heat stress	2/247	82/7349	0.768267531233085	0.893893105402787	0.804914121195241	26353/3303	2	ENSG00000152137,ENSG00000204389	HSPB8,HSPA1A
R-HSA-69242	S Phase	4/247	155/7349	0.771025945263132	0.893893105402787	0.804914121195241	51343/1027/7316/55957	4	ENSG00000105325,ENSG00000111276,ENSG00000150991,ENSG00000267796	FZR1,CDKN1B,UBC,LIN37
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	1/247	43/7349	0.771076251016502	0.893893105402787	0.804914121195241	7316	1	ENSG00000150991	UBC
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	1/247	43/7349	0.771076251016502	0.893893105402787	0.804914121195241	3486	1	ENSG00000146674	IGFBP3
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	2/247	83/7349	0.774092758607447	0.894911103528222	0.805830786802751	51343/7316	2	ENSG00000105325,ENSG00000150991	FZR1,UBC
R-HSA-453276	Regulation of mitotic cell cycle	2/247	83/7349	0.774092758607447	0.894911103528222	0.805830786802751	51343/7316	2	ENSG00000105325,ENSG00000150991	FZR1,UBC
R-HSA-4086398	Ca2+ pathway	1/247	44/7349	0.778815666017724	0.896544514513912	0.807301606479231	2782	1	ENSG00000078369	GNB1
R-HSA-8957322	Metabolism of steroids	3/247	121/7349	0.778918240263015	0.896544514513912	0.807301606479231	8029/10682/1646	3	ENSG00000107611,ENSG00000147155,ENSG00000151632	CUBN,EBP,AKR1C2
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	2/247	84/7349	0.779790210951168	0.896544514513912	0.807301606479231	2067/7316	2	ENSG00000012061,ENSG00000150991	ERCC1,UBC
R-HSA-73886	Chromosome Maintenance	2/247	84/7349	0.779790210951168	0.896544514513912	0.807301606479231	80152/8349	2	ENSG00000102901,ENSG00000184678	CENPT,HIST2H2BE
R-HSA-983189	Kinesins	1/247	45/7349	0.786294451848473	0.902782518788987	0.81291867377591	7277	1	ENSG00000127824	TUBA4A
R-HSA-69052	Switching of origins to a post-replicative state	2/247	86/7349	0.790809671374445	0.906722869781384	0.816466798419759	51343/7316	2	ENSG00000105325,ENSG00000150991	FZR1,UBC
R-HSA-5358351	Signaling by Hedgehog	3/247	125/7349	0.797348389293532	0.910537056313561	0.819901317135773	7277/7316/5034	3	ENSG00000127824,ENSG00000150991,ENSG00000185624	TUBA4A,UBC,P4HB
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	1/247	47/7349	0.800504813320682	0.910537056313561	0.819901317135773	10226	1	ENSG00000105355	PLIN3
R-HSA-73762	RNA Polymerase I Transcription Initiation	1/247	47/7349	0.800504813320682	0.910537056313561	0.819901317135773	30834	1	ENSG00000066379	ZNRD1
R-HSA-73893	DNA Damage Bypass	1/247	47/7349	0.800504813320682	0.910537056313561	0.819901317135773	7316	1	ENSG00000150991	UBC
R-HSA-917937	Iron uptake and transport	1/247	47/7349	0.800504813320682	0.910537056313561	0.819901317135773	7316	1	ENSG00000150991	UBC
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	2/247	88/7349	0.801341781952257	0.910537056313561	0.819901317135773	7316/5600	2	ENSG00000150991,ENSG00000185386	UBC,MAPK11
R-HSA-69206	G1/S Transition	3/247	126/7349	0.801751267028786	0.910537056313561	0.819901317135773	1027/7316/55957	3	ENSG00000111276,ENSG00000150991,ENSG00000267796	CDKN1B,UBC,LIN37
R-HSA-211000	Gene Silencing by RNA	2/247	89/7349	0.806430072201826	0.914304150146103	0.823293430805017	3021/8349	2	ENSG00000132475,ENSG00000184678	H3F3B,HIST2H2BE
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	1/247	48/7349	0.807253007118244	0.914304150146103	0.823293430805017	7316	1	ENSG00000150991	UBC
R-HSA-162599	Late Phase of HIV Life Cycle	3/247	128/7349	0.810317566067083	0.916534868646147	0.82530210142821	5045/7316/51271	3	ENSG00000140564,ENSG00000150991,ENSG00000165006	FURIN,UBC,UBAP1
R-HSA-180534	Vpu mediated degradation of CD4	1/247	49/7349	0.813773827176016	0.917963198579953	0.826588254019048	7316	1	ENSG00000150991	UBC
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	1/247	49/7349	0.813773827176016	0.917963198579953	0.826588254019048	5467	1	ENSG00000112033	PPARD
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	7/247	273/7349	0.818494327411226	0.91832529329889	0.826914305479476	997/51343/6468/10489/7316/80176/9021	7	ENSG00000099804,ENSG00000105325,ENSG00000107829,ENSG00000132128,ENSG00000150991,ENSG00000171621,ENSG00000184557	CDC34,FZR1,FBXW4,LRRC41,UBC,SPSB1,SOCS3
R-HSA-1226099	Signaling by FGFR in disease	1/247	50/7349	0.820074904530471	0.91832529329889	0.826914305479476	6777	1	ENSG00000173757	STAT5B
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	1/247	50/7349	0.820074904530471	0.91832529329889	0.826914305479476	7316	1	ENSG00000150991	UBC
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	1/247	50/7349	0.820074904530471	0.91832529329889	0.826914305479476	7316	1	ENSG00000150991	UBC
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	1/247	50/7349	0.820074904530471	0.91832529329889	0.826914305479476	7316	1	ENSG00000150991	UBC
R-HSA-8951664	Neddylation	5/247	205/7349	0.825303252781395	0.91832529329889	0.826914305479476	6468/10489/7316/80176/9021	5	ENSG00000107829,ENSG00000132128,ENSG00000150991,ENSG00000171621,ENSG00000184557	FBXW4,LRRC41,UBC,SPSB1,SOCS3
R-HSA-169911	Regulation of Apoptosis	1/247	51/7349	0.826163615118356	0.91832529329889	0.826914305479476	7316	1	ENSG00000150991	UBC
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	1/247	51/7349	0.826163615118356	0.91832529329889	0.826914305479476	7316	1	ENSG00000150991	UBC
R-HSA-69610	p53-Independent DNA Damage Response	1/247	51/7349	0.826163615118356	0.91832529329889	0.826914305479476	7316	1	ENSG00000150991	UBC
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	1/247	51/7349	0.826163615118356	0.91832529329889	0.826914305479476	7316	1	ENSG00000150991	UBC
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	1/247	51/7349	0.826163615118356	0.91832529329889	0.826914305479476	7316	1	ENSG00000150991	UBC
R-HSA-180585	Vif-mediated degradation of APOBEC3G	1/247	52/7349	0.832047088270695	0.922415116400757	0.830597023634461	7316	1	ENSG00000150991	UBC
R-HSA-6802952	Signaling by BRAF and RAF fusions	1/247	52/7349	0.832047088270695	0.922415116400757	0.830597023634461	5894	1	ENSG00000132155	RAF1
R-HSA-4641257	Degradation of AXIN	1/247	53/7349	0.837732214925092	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	1/247	54/7349	0.843225655565649	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-2644603	Signaling by NOTCH1 in Cancer	1/247	54/7349	0.843225655565649	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	1/247	54/7349	0.843225655565649	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	1/247	54/7349	0.843225655565649	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	1/247	54/7349	0.843225655565649	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-3214815	HDACs deacetylate histones	1/247	54/7349	0.843225655565649	0.922979359873963	0.831105101766657	8349	1	ENSG00000184678	HIST2H2BE
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	1/247	54/7349	0.843225655565649	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	1/247	54/7349	0.843225655565649	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-5610787	Hedgehog 'off' state	2/247	98/7349	0.84725071686382	0.922979359873963	0.831105101766657	7277/7316	2	ENSG00000127824,ENSG00000150991	TUBA4A,UBC
R-HSA-5387390	Hh mutants abrogate ligand secretion	1/247	55/7349	0.848533847899478	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-69541	Stabilization of p53	1/247	55/7349	0.848533847899478	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-8941858	Regulation of RUNX3 expression and activity	1/247	55/7349	0.848533847899478	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-162587	HIV Life Cycle	3/247	138/7349	0.848600980998254	0.922979359873963	0.831105101766657	5045/7316/51271	3	ENSG00000140564,ENSG00000150991,ENSG00000165006	FURIN,UBC,UBAP1
R-HSA-157579	Telomere Maintenance	1/247	56/7349	0.853663014278533	0.922979359873963	0.831105101766657	8349	1	ENSG00000184678	HIST2H2BE
R-HSA-429914	Deadenylation-dependent mRNA decay	1/247	56/7349	0.853663014278533	0.922979359873963	0.831105101766657	85456	1	ENSG00000149115	TNKS1BP1
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	1/247	56/7349	0.853663014278533	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-72187	mRNA 3'-end processing	1/247	56/7349	0.853663014278533	0.922979359873963	0.831105101766657	6429	1	ENSG00000116350	SRSF4
R-HSA-71387	Metabolism of carbohydrates	5/247	215/7349	0.85508205967871	0.922979359873963	0.831105101766657	3423/6385/7316/55454/3037	5	ENSG00000010404,ENSG00000124145,ENSG00000150991,ENSG00000169826,ENSG00000170961	IDS,SDC4,UBC,CSGALNACT2,HAS2
R-HSA-375276	Peptide ligand-binding receptors	1/247	57/7349	0.858619168875161	0.922979359873963	0.831105101766657	301	1	ENSG00000135046	ANXA1
R-HSA-5610780	Degradation of GLI1 by the proteasome	1/247	57/7349	0.858619168875161	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-5610783	Degradation of GLI2 by the proteasome	1/247	57/7349	0.858619168875161	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	1/247	57/7349	0.858619168875161	0.922979359873963	0.831105101766657	7316	1	ENSG00000150991	UBC
R-HSA-68875	Mitotic Prophase	2/247	101/7349	0.859021411400021	0.922979359873963	0.831105101766657	3021/8349	2	ENSG00000132475,ENSG00000184678	H3F3B,HIST2H2BE
R-HSA-5617833	Cilium Assembly	4/247	180/7349	0.860925976707523	0.923738191915343	0.831788398932762	8655/7277/5116/9814	4	ENSG00000088986,ENSG00000127824,ENSG00000160299,ENSG00000198089	DYNLL1,TUBA4A,PCNT,SFI1
R-HSA-8978868	Fatty acid metabolism	3/247	142/7349	0.861934919815869	0.923738191915343	0.831788398932762	5467/2879/122970	3	ENSG00000112033,ENSG00000167468,ENSG00000177465	PPARD,GPX4,ACOT4
R-HSA-5678895	Defective CFTR causes cystic fibrosis	1/247	58/7349	0.863408124619515	0.924133759982781	0.832144591772208	7316	1	ENSG00000150991	UBC
R-HSA-453279	Mitotic G1-G1/S phases	3/247	143/7349	0.865103837568199	0.924766171193592	0.832714052159482	1027/7316/55957	3	ENSG00000111276,ENSG00000150991,ENSG00000267796	CDKN1B,UBC,LIN37
R-HSA-8878166	Transcriptional regulation by RUNX2	2/247	104/7349	0.869960167795103	0.928771250566966	0.836320462058665	7316/3678	2	ENSG00000150991,ENSG00000161638	UBC,ITGA5
R-HSA-69481	G2/M Checkpoints	3/247	145/7349	0.871251022589054	0.928964466123616	0.836494444751945	9025/7316/8349	3	ENSG00000112130,ENSG00000150991,ENSG00000184678	RNF8,UBC,HIST2H2BE
R-HSA-1989781	PPARA activates gene expression	2/247	105/7349	0.87343015878618	0.930103108020398	0.837519745133126	51586/10025	2	ENSG00000099917,ENSG00000175221	MED15,MED16
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	1/247	61/7349	0.876827048706658	0.932533976832875	0.839708642913084	3725	1	ENSG00000177606	JUN
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	1/247	64/7349	0.888932495078903	0.937103629621969	0.84382342804418	7277	1	ENSG00000127824	TUBA4A
R-HSA-1483206	Glycerophospholipid biosynthesis	2/247	111/7349	0.892523790143646	0.937103629621969	0.84382342804418	63874/56261	2	ENSG00000100439,ENSG00000125772	ABHD4,GPCPD1
R-HSA-5696398	Nucleotide Excision Repair	2/247	111/7349	0.892523790143646	0.937103629621969	0.84382342804418	2067/7316	2	ENSG00000012061,ENSG00000150991	ERCC1,UBC
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	1/247	65/7349	0.892698270468815	0.937103629621969	0.84382342804418	6429	1	ENSG00000116350	SRSF4
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	1/247	65/7349	0.892698270468815	0.937103629621969	0.84382342804418	7316	1	ENSG00000150991	UBC
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	1/247	65/7349	0.892698270468815	0.937103629621969	0.84382342804418	3303	1	ENSG00000204389	HSPA1A
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	1/247	65/7349	0.892698270468815	0.937103629621969	0.84382342804418	7316	1	ENSG00000150991	UBC
R-HSA-68867	Assembly of the pre-replicative complex	1/247	65/7349	0.892698270468815	0.937103629621969	0.84382342804418	7316	1	ENSG00000150991	UBC
R-HSA-73856	RNA Polymerase II Transcription Termination	1/247	65/7349	0.892698270468815	0.937103629621969	0.84382342804418	6429	1	ENSG00000116350	SRSF4
R-HSA-8948751	Regulation of PTEN stability and activity	1/247	65/7349	0.892698270468815	0.937103629621969	0.84382342804418	7316	1	ENSG00000150991	UBC
R-HSA-5633007	Regulation of TP53 Activity	3/247	153/7349	0.893439302793705	0.937103629621969	0.84382342804418	10848/7316/5600	3	ENSG00000104881,ENSG00000150991,ENSG00000185386	PPP1R13L,UBC,MAPK11
R-HSA-5685942	HDR through Homologous Recombination (HRR)	1/247	66/7349	0.89633686563551	0.937792445671152	0.844443678677665	7316	1	ENSG00000150991	UBC
R-HSA-8939902	Regulation of RUNX2 expression and activity	1/247	66/7349	0.89633686563551	0.937792445671152	0.844443678677665	7316	1	ENSG00000150991	UBC
R-HSA-5619084	ABC transporter disorders	1/247	67/7349	0.8998525589196	0.939122932438535	0.845641727505491	7316	1	ENSG00000150991	UBC
R-HSA-68949	Orc1 removal from chromatin	1/247	67/7349	0.8998525589196	0.939122932438535	0.845641727505491	7316	1	ENSG00000150991	UBC
R-HSA-69239	Synthesis of DNA	2/247	115/7349	0.903733238852205	0.941398242794066	0.84769055126775	51343/7316	2	ENSG00000105325,ENSG00000150991	FZR1,UBC
R-HSA-3700989	Transcriptional Regulation by TP53	8/247	348/7349	0.905765285169709	0.941398242794066	0.84769055126775	10848/1027/25824/3486/85456/7316/3725/5600	8	ENSG00000104881,ENSG00000111276,ENSG00000126432,ENSG00000146674,ENSG00000149115,ENSG00000150991,ENSG00000177606,ENSG00000185386	PPP1R13L,CDKN1B,PRDX5,IGFBP3,TNKS1BP1,UBC,JUN,MAPK11
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	1/247	69/7349	0.906531641209101	0.941398242794066	0.84769055126775	6429	1	ENSG00000116350	SRSF4
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	1/247	69/7349	0.906531641209101	0.941398242794066	0.84769055126775	7316	1	ENSG00000150991	UBC
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	1/247	70/7349	0.909702889096649	0.943520840364182	0.849601863422945	7316	1	ENSG00000150991	UBC
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	2/247	119/7349	0.913846932108666	0.946645893780883	0.852415846000267	7277/3021	2	ENSG00000127824,ENSG00000132475	TUBA4A,H3F3B
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	1/247	72/7349	0.91572746765057	0.947421372587796	0.853114132896764	7316	1	ENSG00000150991	UBC
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	1/247	73/7349	0.918587893030577	0.949207489464929	0.85472245797257	7316	1	ENSG00000150991	UBC
R-HSA-69306	DNA Replication	2/247	122/7349	0.920770888928501	0.950290054294889	0.855697263252394	51343/7316	2	ENSG00000105325,ENSG00000150991	FZR1,UBC
R-HSA-351202	Metabolism of polyamines	1/247	75/7349	0.924021869596916	0.951299267961401	0.856606018814517	54498	1	ENSG00000088826	SMOX
R-HSA-5632684	Hedgehog 'on' state	1/247	75/7349	0.924021869596916	0.951299267961401	0.856606018814517	7316	1	ENSG00000150991	UBC
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	1/247	78/7349	0.931502885678797	0.9578229917852	0.862480364859716	6429	1	ENSG00000116350	SRSF4
R-HSA-5628897	TP53 Regulates Metabolic Genes	1/247	80/7349	0.936077920998783	0.961218163746812	0.865537578120753	25824	1	ENSG00000126432	PRDX5
R-HSA-68874	M/G1 Transition	1/247	81/7349	0.938249987791093	0.961218163746812	0.865537578120753	7316	1	ENSG00000150991	UBC
R-HSA-69002	DNA Replication Pre-Initiation	1/247	81/7349	0.938249987791093	0.961218163746812	0.865537578120753	7316	1	ENSG00000150991	UBC
R-HSA-5173105	O-linked glycosylation	1/247	82/7349	0.940348536637488	0.962190373063054	0.86641301278142	10418	1	ENSG00000262655	SPON1
R-HSA-1852241	Organelle biogenesis and maintenance	5/247	269/7349	0.952151616859461	0.970065620020933	0.873504350040858	8655/7277/5116/5600/9814	5	ENSG00000088986,ENSG00000127824,ENSG00000160299,ENSG00000185386,ENSG00000198089	DYNLL1,TUBA4A,PCNT,MAPK11,SFI1
R-HSA-1592230	Mitochondrial biogenesis	1/247	89/7349	0.953177933111136	0.970065620020933	0.873504350040858	5600	1	ENSG00000185386	MAPK11
R-HSA-382556	ABC-family proteins mediated transport	1/247	89/7349	0.953177933111136	0.970065620020933	0.873504350040858	7316	1	ENSG00000150991	UBC
R-HSA-5689603	UCH proteinases	1/247	89/7349	0.953177933111136	0.970065620020933	0.873504350040858	7316	1	ENSG00000150991	UBC
R-HSA-211859	Biological oxidations	2/247	141/7349	0.953839910725482	0.970065620020933	0.873504350040858	54498/9049	2	ENSG00000088826,ENSG00000110711	SMOX,AIP
R-HSA-376176	Signaling by ROBO receptors	3/247	190/7349	0.957604269761771	0.971650984042713	0.874931905394683	4650/5216/7316	3	ENSG00000099331,ENSG00000108518,ENSG00000150991	MYO9B,PFN1,UBC
R-HSA-8878159	Transcriptional regulation by RUNX3	1/247	92/7349	0.957796748348648	0.971650984042713	0.874931905394683	7316	1	ENSG00000150991	UBC
R-HSA-168254	Influenza Infection	2/247	145/7349	0.958881377322916	0.971650984042713	0.874931905394683	402569/3303	2	ENSG00000185467,ENSG00000204389	KPNA7,HSPA1A
R-HSA-72766	Translation	5/247	282/7349	0.964136766253688	0.975795010101979	0.878663431092269	23438/23480/6727/6730/6734	5	ENSG00000112855,ENSG00000132432,ENSG00000140319,ENSG00000167881,ENSG00000182934	HARS2,SEC61G,SRP14,SRP68,SRPR
R-HSA-196854	Metabolism of vitamins and cofactors	2/247	154/7349	0.968371720270675	0.978897499838835	0.881457096000258	8029/6385	2	ENSG00000107611,ENSG00000124145	CUBN,SDC4
R-HSA-71291	Metabolism of amino acids and derivatives	5/247	292/7349	0.971412341884178	0.980786646751576	0.883158195402287	54498/3081/58472/120103/125061	5	ENSG00000088826,ENSG00000113924,ENSG00000137767,ENSG00000180773,ENSG00000183077	SMOX,HGD,SQRDL,SLC36A4,AFMID
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	1/247	105/7349	0.973104917595897	0.981311826539477	0.883631098286192	8029	1	ENSG00000107611	CUBN
R-HSA-73894	DNA Repair	4/247	288/7349	0.989140054057513	0.996135845499131	0.896979520062099	2067/9025/7316/8349	4	ENSG00000012061,ENSG00000112130,ENSG00000150991,ENSG00000184678	ERCC1,RNF8,UBC,HIST2H2BE
R-HSA-168255	Influenza Life Cycle	1/247	134/7349	0.990185213208216	0.996135845499131	0.896979520062099	3303	1	ENSG00000204389	HSPA1A
R-HSA-9010553	Regulation of expression of SLITs and ROBOs	1/247	153/7349	0.994940825106537	0.998694027873512	0.899283058488882	7316	1	ENSG00000150991	UBC
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	1/247	154/7349	0.99511447938651	0.998694027873512	0.899283058488882	5467	1	ENSG00000112033	PPARD
R-HSA-72163	mRNA Splicing - Major Pathway	1/247	180/7349	0.998033173368086	0.999708837216303	0.900196852728256	6429	1	ENSG00000116350	SRSF4
R-HSA-72172	mRNA Splicing	1/247	188/7349	0.998514441950812	0.999708837216303	0.900196852728256	6429	1	ENSG00000116350	SRSF4
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	1/247	236/7349	0.999726026650247	0.999726026650247	0.900212331109322	6429	1	ENSG00000116350	SRSF4
